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ABSTRACT 
Background 
Cardiovascular disease (CVD) is a major cause of death worldwide and is preceded by a long 
process in which several cardiovascular (CV) risk factors are present, sometimes already in 
childhood. Some of these risk factors such as non-dipping blood pressure and microvascular 
endothelial dysfunction and possible associated factors are little studied among children with 
obesity. In addition to these CV risk factors, obesity in childhood is also associated with 
adverse CV health in general populations adults. However, the clinical value of childhood 
CV risk factors for identifying children at increased risk of adverse end-organ function in 
young adulthood is unclear. Weight loss is effective for improving CV risk factors but is 
found to be hard to achieve especially among adolescents with obesity. As such, new 
approaches to diminish their CV risk must be evaluated. 
Aims 
In Study I, acetylcholine-induced endothelium-dependent vasodilatation was compared 
between children with obesity and children with normal weight. Associations between 
vasodilatation and potential risk factors were also studied. 
In Study II, the prevalence of nocturnal blood pressure dipping among prepubertal and early 
pubertal children with obesity was studied. In addition, associations between dipping and 
measures of insulin-glucose metabolism or sleep-disordered breathing were evaluated. 
In Study III, the aim was to evaluate whether well-established cardiovascular risk factors 
could be used clinically for the early identification of children and adolescents with obesity 
at risk of a rapid deterioration in cardiovascular health in young adulthood. 
In Study IV, the aim was to evaluate whether regular supervised individualised aerobic 
exercise for a period of three months could increase cardiorespiratory fitness (CRF), lead to 
improved long-term CRF, and affect CV risk factors among adolescents in obesity treatment. 
Subjects and methods 
In Study I, endothelium-dependent vasodilatation was compared between 54 children (14.3 
years old, 41% girls) with obesity and 44 (13.7 years old, 82% girls) normal-weight children. 
Acetylcholine was administered via transdermal iontophoresis to induce vasodilatation in the 
dorsal hand skin, and the subsequent change in perfusion was measured with laser Doppler 
flowmetry. In a subgroup of children with obesity, associations between acetylcholine-
induced vasodilatation and inflammation, 24-hour ambulatory blood pressure (ABP), CRF, 
blood lipids, glucose/insulin metabolism, and duration of obesity were evaluated. 
In Study II, non-dipping—measured via 24-hour ABP and defined as nocturnal blood 
pressure reduction lower than 10%—was studied among 76 (10.4 years old, 41% girls) 
prepubertal and early pubertal children with obesity. Frequently sampled intravenous 
glucose-tolerance tests, fasting blood samples, and polygraph recordings were performed to 
study associations between dipping, insulin/glucose metabolism and sleep-disordered 
breathing. As a measure of end-organ damage, left ventricular mass (LVM) was measured 
using echocardiography and associations with the above factors were evaluated. 
The longitudinal, prospective cohort of Study III included 49 young adults (23.4 years old, 
25 females) who had been extensively examined before entering a childhood obesity 
treatment program at an age of 13.8 years. At inclusion, 24-hour ambulatory blood pressure, 
blood lipids, CRF, and metabolic syndrome score were determined. Five to fifteen years later, 
a comprehensive cardiovascular follow-up was performed in which left ventricular mass, 
carotid intima-media thickness, arterial stiffness and endothelial function were considered as 
main outcomes.  
In Study IV, eight adolescents (15.1 years old) undergoing obesity treatment performed 
regular individualised aerobic exercise, supervised by a personal coach, for 3 months. The 
exercise was performed at an intensity of ≥ 150 bpm, for ≥ 30 minutes, 3 times per week. The 
adolescent was responsible for performing the exercise over the following 9 months. 
Biochemical factors (blood lipids, glucose, insulin and markers of inflammation), ambulatory 
blood pressure, body composition, endothelial function, arterial stiffness, CRF, metabolic 
syndrome score, pediatric health-related quality of life and objectively measured physical 
activity) were assessed before and after the 3 months of supervised exercise, and 9 months 
after the end of the supervised exercise. 
Results 
In Study I, endothelium-dependent vasodilatory response to acetylcholine was lower in 
children with obesity compared with normal-weight children (p < 0.001), and peak perfusion 
was 33% lower among children with obesity (p = 0.001). The lowest vasodilatation was 
found among children with the shortest duration of obesity (p = 0.03). Except for a trend in 
association between vasodilatation and triglycerides (p = 0.07) no associations were found 
with 24-hour ABP, CRF, inflammation, or insulin/glucose metabolism. 
Study II showed a prevalence of 42% systolic non-dippers and 17% diastolic non-dippers 
among prepubertal and early pubertal children with obesity. Systolic and diastolic dipping 
were not associated with measures of insulin/glucose metabolism (adjusted for BMI SDS, sex 
and pubertal status) or with measures of sleep-disordered breathing. No associations were 
found between LVM index as a measure of end-organ damage and measures of blood 
pressure (p = 0.2–0.9), insulin/glucose metabolism (p = 0.2–0.9) or measures of sleep-
disordered breathing (p = 0.3–1.0) (adjusted for BMI SDS, sex, and pubertal status). 
In Study III, childhood total serum cholesterol, triglycerides and daytime systolic blood 
pressure were positively associated with carotid intima-media thickness independent of sex 
and change in BMI SDS at follow up (p < 0.05). High blood pressure or dyslipidaemia in 
childhood did not predict increased left ventricular mass index, arterial stiffness, or 
endothelial dysfunction in young adult life. The strongest tracking correlations were for 
  
daytime diastolic blood pressure (r = 0.56, p < 0.01) and total cholesterol (r = 0.75, 
p < 0.001). At follow-up, severe obesity was present in 74% of subjects, although one-third 
had decreased their BMI SDS > 0.25 BMI SDS from childhood.  
In Study IV, supervised exercise increased absolute and relative CRF (0.65 ± 0.41, p = 0.01 
and 6.02 ± 3.69, p = 0.01, respectively), but did not improve the CV risk factor profile or 
long-term CRF. Arterial stiffness decreased 9 months after the supervised exercise (-16 ± 11 
units, p = 0.03), whereas gynoid fat percentage (1 ± 1 %, p = 0.04) and apolipoprotein B 
(0.11 ± 0.08 g/L, p = 0.01) increased. 
Conclusions 
Children with obesity without comorbidities have impaired microvascular endothelial 
function compared with normal-weight children. Children with a longer duration of obesity, 
however, seem less affected. In addition, nocturnal non-dipping was highly present among 
prepubertal and early pubertal children with obesity. Compared with previous reports on 
children in general, non-dipping was about two times higher among children with obesity. No 
associations between dipping and insulin/glucose metabolism or measures of sleep-
disordered breathing were found. 
Few associations between childhood CV risk factors and end-organ function in young adults 
previously attending childhood obesity treatment were found. However, childhood serum 
cholesterol, triglycerides, and systolic blood pressure were associated with carotid intima- 
media thickness, but not with other intermediate markers of increased cardiovascular risk in 
young adult life. Clinicians should evaluate blood lipids and 24-hour ABP and perhaps treat 
these factors, if elevated, starting in childhood to reduce the future risk of CVD these subjects 
appear to be exposed to. 
In this small but comprehensive study of the effects of supervised aerobic exercise in 
adolescents with obesity, it was found that short-term CRF increased, but there were no other 
statistically significant effects on CV risk factor profile or weight. The improved CRF was 
not maintained long-term when the adolescents exercised on their own, and the effect on CV 
risk factors was still absent, except for improved arterial stiffness. This exercise regimen 
cannot therefore be recommended for clinical implementation as a complement to childhood 
obesity treatment to reduce CV risk factors without weight reduction. 
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1 BACKGROUND 
Overweight and obesity are common not only among adults, but also among children and 
adolescents (1). Overweight and obesity can be caused or triggered by endocrine disorders 
and genetic, epigenetic, environmental and social factors. However, most of the time, the 
cause is excessive energy intake from too much food and food that is too energy-dense, such 
as fast foods, sweets, soft drinks, or snacks. Excessive energy intake is often seen in 
combination with low daily physical activity and low levels, or even the absence, of physical 
exercise. This creates an imbalance between the energy intake and energy output, leading to 
overweight and obesity (2).  
Increased body mass index (BMI) in adolescence is related to morbidity and mortality in 
adulthood (3), such as cardiovascular disease (CVD). Among non-communicable diseases 
(NCD), CVD is the main cause of death worldwide (4) and in Sweden (5). Years of life lost 
for young adults aged 20 to 30 years due to obesity are 13 years for men and 8 years for 
women (6).  
Normally, CVD is unusual among children and adolescents, but the natural development of 
CVD starts in childhood (7, 8) and worsens with age (9), and is modified by the presence of 
other cardiovascular (CV) risk factors. CVD usually occurs later in life (10). CVD (e.g. 
coronary heart disease (CHD) and stroke) is, however, preceded by atherosclerosis, which is 
the narrowing of arteries. Atherosclerosis is developed in a long process throughout life, 
starting in childhood, with numerous factors acting in the blood vessels contributing to its 
development (7, 8, 11). Low-grade inflammation, adverse levels of blood lipids and 
hypertension are some of the risk factors contributing to atherosclerosis. These risk factors 
are present at an early stage of life among those with obesity (7, 12). In autopsy studies in 
children and young adults, the amount of fatty streaks and plaque in the aorta and coronary 
arteries was associated with the number of CV risk factors (9). Circulating inflammatory 
markers enhance the process of accumulation of fat into fatty streaks, and these later develop 
into stable or unstable fibrous plaques; these are the main steps in the progress of 
atherosclerosis. When an unstable plaque, with its thin fibrous cap, suddenly ruptures, and 
clotting factors are recruited to the rupture to block the bleeding, a CVD event occurs (8, 11). 
The health care costs from obesity rise along with age and the number of obesity-related 
diseases (13). Treating obesity as early as possible, or at least reducing the risk factors for 
CVD that are usually present, should be a social and health care priority. 
1.1 OBESITY IN CHILDREN AND ADOLESCENTS 
1.1.1 Definitions 
The World Health Organisation (WHO) uses BMI to classify the degree of obesity. The range 
or cut-offs for overweight, obesity and severe obesity in adults are BMIs of 25.0–29.9, 30.0–
34.9 and ≥ 35.0, respectively, when taking into account the risk of comorbidities (14). 
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Generally, it can be assumed that a BMI of 30 is equivalent to an excess of body fat, although 
BMI unfortunately does not discriminate between fat mass weight and muscle mass weight. 
In children and adolescents, height and body composition change with age. To classify the 
degree of obesity in children and adolescents using BMI, age and sex have to be accounted 
for. The International Obesity Task Force (IOTF) has adapted the adult obesity classification 
to children and adolescents based on age- and sex- specific cut-offs (15, 16). The BMI 
standard deviation score (SDS) is suitable for following weight status over time or comparing 
weight status between groups. Several references are available, among them, the IOTF’s 
international reference population (16), Roland-Cachera et al.’s French reference population 
(17), and Karlberg et al.’s Swedish reference population (18). It is important, however, to 
keep in mind that the prevalence of obesity is dependent on which reference is used.  
1.1.2 Prevalences and trends 
1.1.2.1 Worldwide 
The trends in BMI between 1975 and 2016 among children and adolescents aged 5–19 years 
in 200 countries have been presented in a comprehensive worldwide population-based study 
of pooled data (19). Between those years, the global prevalence of obesity among children 
and adolescents increased from 0.7% to 5.6% in girls, and 0.9% to 7.8% in boys. The 
prevalence of obesity was over 30% in some countries, and about 20% in some African areas 
and the USA. The increase of obesity among children and adolescents has reached a plateau 
in many high-income countries, but at high levels. However, in parts of Asia, for example, 
obesity is still accelerating. On the other hand, Niger, Ethiopia, Chad and Burkina Faso are 
among countries with a prevalence of obesity of about 2%. 
1.1.2.2 In Sweden 
National data on obesity among children and adolescents in Sweden is rare. However, 
between the years 1999 and 2005, in selected areas of Sweden the prevalence of obesity 
among 10-year-old school children was about 3%–5% (20). In a later study of school children 
aged 7–9 in West Sweden, the prevalence of obesity was 3.2%, 3.3% and 3.1 % in 2008, 
2010 and 2013, respectively (21). In a recent nationwide study of Swedish school children 
aged 12, 15, and 18 the prevalence of obesity was 4%, 3%, and 6%, respectively (22). 
However, in an additional group of adolescents aged 19 who are not attending ordinary 
school programmes, or are working, the prevalence of obesity was 23%; unfortunately, it was 
not possible to randomise this sample in order to be nationally representative (22). 
Overweight and obesity were more prevalent among those with a less advantaged 
socioeconomic status (20, 21) and lower level of education (22). There are also regional 
differences, with a higher prevalence of obesity in sparsely populated areas (22). 
1.1.3 Tracking into adulthood 
According to the results of a systematic review and meta-analysis, 55% of the children with 
obesity will become adolescents with obesity (23). Among the adolescents with obesity, 80% 
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will have obesity as adults, and 70% will still have obesity at the age of 30. However, 70% of 
adults with obesity were not obese during childhood or adolescence. Even though the 
majority of obese adults were not obese as children, the health care costs for adults with 
obesity will rise in the future along with the number of CV risk factors present (13). Treating 
obesity as early as possible, or at least improving the CV risk factors present, would be 
beneficial. 
1.2 OBESITY-RELATED CARDIOVASCULAR RISK FACTORS 
1.2.1 Risk factors versus risk markers 
The expression “risk factor” is commonly used when writing about factors that increase the 
risk of, for example, CVD. However, some of the risk factors might by definition be risk 
markers rather than risk factors. Risk factors have a causal association with the outcome 
disease evaluated in a longitudinal study. The presence of a risk factor directly increases the 
risk of having a disease, but the risk will be reduced if the risk factor is absent or removed 
(24). There are also known risk factors that by their nature are untreatable, such as gender, 
age, genetics, and a family history of CVD (25). A risk marker may be associated with the 
disease, but not be causal (24). However, the term “risk factor” will be used for all risk 
factors and risk markers included in this thesis. 
Another aspect of the concept of risk factors is that in the young populations studied in this 
thesis, manifest CVD is not present. Therefore, some of the risk factors for CVD are, when 
relevant, evaluated as preclinical markers of CVD, and treated as markers of end-organ 
function in this thesis. 
1.2.2 Cardiovascular risk factors in childhood 
Obesity itself is a risk factor for CVD (26), and is usually accompanied by other common risk 
factors for CVD (27-31). However, it must be noted that some people are considered to be 
metabolically-healthy individuals with obesity, meaning that obesity-related CV risk factors 
are not present, or at least not to the same extent as normally seen in the obese. The risk of 
future CVD is therefore lower for these subjects (32). 
 
1.2.2.1 Influence of puberty on cardiovascular risk factors 
Childhood obesity modifies the time of entering puberty, especially for girls (33). For boys, 
the data are insufficient and the association is inconsistent. In boys, the start of puberty might 
be delayed (34, 35) and, consequently, fewer boys than girls of the same age may have started 
puberty.  However, metabolic health is altered during puberty in both girls and boys with 
obesity (36). When entering puberty—Tanner stages 2–3 (early pubertal) (37) —the risk of 
metabolically-unhealthy obesity is doubled. But leaving Tanner stages 2–3 and entering late 
puberty (Tanner stages 4–5), the chances of metabolically-healthy obesity again tripled. 
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Prevalences of cardiovascular risk factors such as hypertension, hypertriglyceridemia, 
impaired fasting glucose level, and the measure of insulin resistance became worse among 
children and adolescents with obesity when entering puberty. However, when entering late 
puberty these prevalences decreased, and the measure of insulin resistance was only weakly 
associated with the prevalences of these CV risk factors. This suggests that other factors 
besides insulin resistance contribute to metabolic changes during puberty (38). 
1.2.2.2 Abnormal blood lipid levels 
Abnormal levels of blood lipids are early biochemical signs of an unhealthy and excessive 
diet, and usually contribute to overweight and obesity. These blood lipids are involved in the 
formation of atherosclerotic plaque, and are therefore an example of a risk factor for 
atherosclerotic diseases  (39). Decreased high-density lipoprotein (HDL) cholesterol and 
increased low-density lipoprotein (LDL) cholesterol, the ratio of LDL cholesterol and HDL 
cholesterol (LDL/HDL), triglycerides and total cholesterol are already present among 
children and adolescents with obesity (12, 31), and are traditionally used to evaluate the 
blood lipid profile. The apolipoproteins, apolipoprotein A1 (APO A1) and apolipoprotein B 
(APO B), are attached to the surface of the lipids to facilitate the transport of different kinds 
of hydrophobic lipid compounds in the blood. When measuring apolipoproteins, a larger 
fraction of blood lipids can be detected. Together with the ratio of APO A1 and APO B, it has 
been suggested that the apolipoproteins are a more accurate measure of the total amount of 
blood lipids and subsequent CV risk (40); however, according to others, they may not be 
superior to traditional measures (39). 
1.2.2.3 Impaired insulin and glucose metabolism 
Insulin resistance (41) and elevated glucose levels (42) are present in childhood obesity. In 
adolescents with type 1 diabetes, impaired insulin metabolism is related to the early 
development of CVD as a result of impairment in the nocturnal blood pressure fall (43). In 
otherwise healthy adolescents with obesity, a higher degree of insulin resistance was also 
related to lower HDL cholesterol (44). An elevated glucose level is not only a risk factor for 
type 2 diabetes mellitus (T2DM) (45), but glucose is also related to intima-media thickness 
(IMT) in adolescents with obesity (46).  
1.2.2.4 Low grade inflammation 
Inflammation is related to the aetiology of atherosclerosis (25, 47). There are several (45) 
biochemical markers that indicate an on-going inflammatory process. However, in health care 
and many studies, the inflammatory marker high sensitive C-reactive protein (hs-CRP) is 
common. Low-grade inflammation (increased hs-CRP levels) is accompanied by increased 
IMT not only in childhood obesity (48), but also in healthy children, although not measured 
as hs-CRP (49). 
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1.2.2.5 Hypertension 
In the growing child, blood pressure naturally increases with age, and therefore references 
need to be based on gender, age and height (50, 51). However, blood pressure has also 
increased among children and adolescents over time (52), probably partly due to the parallel 
increase in the prevalence of overweight and obesity (53). In children and adolescents, an 
increased BMI is associated with an increased risk of hypertension (54). Hypertension is a 
strong risk factor for CVD in adults (55), and often coexists with non-dipping (56), as well as 
being associated with several preclinical stages of CVD in children with obesity (57). 
1.2.2.6 Nocturnal blood pressure non-dipping 
Normally, the blood pressure lowers by > 10% from daytime to night (referred to as dipping) 
in healthy children and adolescents, but if it lowers by less than 10%, it is referred to as non-
dipping (58). Nocturnal blood pressure dipping is less pronounced in children with obesity 
(59), although the mechanisms are still unclear. Among a population of Swedish adolescents 
with obesity, 50% were nocturnal systolic non-dippers (60). Independent of hypertension, 
non-dipping in adults predicts left ventricular hypertrophy (LVH) (61, 62), end-organ 
function, CVD (62), and mortality (63). Non-dipping status is also related to cIMT in adults 
(64). However, among fairly normotensive adolescents with obesity, the association between 
dipping and left ventricular mass (LVM) seems to not be as pronounced (60).  
In younger children with obesity, the relationship of non-dipping to CV risk factors has been 
little studied. Marcovecchio et al. found no associations between childhood dippers and non-
dippers and obesity and measures of insulin and glucose metabolism (65). An association 
between non-dipping and left ventricular dysfunction (66) has been found among adolescents 
with type 1 diabetes. Among children and adolescents with type 1 diabetes, high nocturnal 
blood pressure is also associated with higher cIMT (67). In more recent studies, non-dipping 
has not been associated with increased LVM index in either children or adolescents with 
obesity and suspected hypertension (68), or among non-obese but hypertensive children (69). 
1.2.2.7 Endothelial dysfunction 
Endothelial dysfunction is one of the first detectible steps in the development of 
atherosclerotic diseases (70). Endothelial dysfunction contributes to conditions such as 
increased blood pressure and atherosclerosis through mechanisms involving the production of 
inflammatory and vasoconstriction factors, the uptake of lipids to the vascular structure, and 
the reduced production of vasodilating factors such as the highly important nitrogen oxide 
(NO) produced by the endothelial cells (71). Endothelial function can be evaluated both in the 
macrovasculature (brachial and femoral arteries) and microvasculature (arterioles and 
capillaries) (72). Microvascular endothelial function among children and adolescents with 
obesity has been poorly studied compared to macrovascular endothelial function. In high 
cardiovascular risk adults, macrovascular and microvascular dysfunction are correlated, but 
this relationship is unclear in children with obesity (72).  
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1.2.2.8 Arterial stiffness 
Arterial stiffness is an early subclinical marker of CVD (73) that can be detected before CVD 
appears. It is possible to measure arterial stiffness at different sites in the vascular tree, 
depending on the method used (74). Arterial stiffness is already present in children with 
obesity (75-77). 
1.2.2.9 Increased intima-media thickness 
Increased cIMT is a marker of the early atherosclerotic process involving plaque formation in 
the intima layer of the artery (47), and predicts the risk of CVD in adults (78). Increased 
cIMT is found in children and adolescents with obesity (28, 79), though it may not be 
dependent on the adiposity itself (80), but on the presence of other risk factors, at least in 
children (81). 
1.2.2.10 Left ventricular hypertrophy 
LVH is a marker of increased risk for CVD (82). LVH is present in children and adolescents 
with obesity (83, 84) irrespective of blood pressure status (85), though it is thought to be 
affected to a greater extent when both obesity and hypertension are present (86). 
1.2.2.11 Metabolic syndrome 
In children and adolescents, the prevalence of metabolic syndrome (MetS) increases with the 
degree of obesity. In severely obese youths, the prevalence is about 50%, and is related to 
insulin resistance (87). Among adolescents, most of them obese, MetS is also associated with 
a higher prevalence of LVH (88).  
1.2.2.12 Influence of obstructive sleep apnoea on cardiovascular risk factors 
Obstructive sleep apnoea (OSA) is present in children with obesity (31). In children, OSA is 
associated with insulin resistance, hypertension, and metabolic consequences (89). In adults, 
OSA also increases the risk of CVD and overall mortality (90). 
1.2.2.13 Influence of low physical activity and cardiorespiratory fitness on cardiovascular 
risk factors 
Physical activity involves any bodily movement produced by skeletal muscles that results in 
energy expenditure higher than basal levels, and is related to physical fitness. The effect of 
physical activity depends on the intensity, frequency and duration. The intensity of physical 
activity can be expressed as the metabolic equivalent (MET), which is related to the oxygen 
consumption per kilogram of body weight and minutes of physical activity performed (91).  
Exercise is one part of physical activity, and is planned, structured and repetitive bodily 
movement related to physical fitness. Exercise is intended to maintain or improve 
components of physical fitness. Cardiorespiratory fitness (CRF) is one component of physical 
fitness, and refers to the ability of the circulatory and respiratory systems to supply the 
skeletal muscles with oxygen during work (91). CRF is measured as the maximum oxygen 
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uptake (VO2 max), which is limited by the capacity of heart, lungs and blood (the 
cardiorespiratory system) (92). 
Low physical activity levels have been associated with an increased degree of obesity among 
children and adolescents (93). In adults, low physical activity levels and CRF are risk factors 
for CVD, but also interact with other CV risk factors, such as increased blood glucose, blood 
pressure, and blood lipids (94), and increased cIMT (95). Although it has not been studied to 
the same extent as in adults, the relationship of low physical activity and CRF with CV risk 
factors is also present among children and adolescents both with (96) and without obesity 
(97). CRF has been found to be more strongly correlated to risk factors than physical activity 
(98). In children and adolescents, greater CRF was associated with better arterial stiffness as 
measured by augmentation index, but not by pulse wave velocity (99). In another population-
based study of adolescents, CRF was associated with arterial stiffness, but not cIMT (100). 
Central and total adiposity are higher in parallel with low CRF among children with obesity 
(101). 
1.2.2.14 Influence of smoking and parental smoking on cardiovascular risk factors 
Both smoking and passive smoking (102) exert a direct adverse effect on health in children 
and adults. In addition, endothelial function (103) and increased cIMT (104) in adulthood 
have been associated with exposure to environmental or parental smoking during childhood, 
even when adjusted for adult smoking status. 
1.2.3 Tracking of childhood cardiovascular risk factors into adulthood 
About 55% of children with obesity will still have obesity in adolescence. About 80% of 
adolescents with obesity will have obesity in adulthood, and 70% will have obesity after the 
age of 30. However, 70% of the adults with obesity did not have obesity in childhood (23). 
As described above, CV risk factors are present along with obesity, and several of these CV 
risk factors are also seen tracking into adulthood. 
Blood pressure (both in-office and 24-hour ambulatory blood pressure monitoring (ABPM) 
(105, 106)), blood lipids, and BMI measured in childhood are strongly related to levels seen 
in adulthood (107), although measurements of glucose are not (108). CRF also tracks into 
adulthood, although not very strongly (109). There is low tracking for the dichotomised MetS 
variable from adolescence to young adulthood, but the tracking of the cluster score of the 
MetS-components seems more relevant (110). Those categorized as metabolically-healthy 
obese in childhood were more likely to remain so into adulthood (32).Tracking of vascular 
structure and function from childhood to adulthood is less studied, however arterial stiffness 
seems to track over a 5-year period from early to late adolescence (75). 
Even though childhood BMI tracks into adulthood (23, 107), changes in the degree of obesity 
from childhood to adulthood influence the tracking of CV risk factors, and hence the risk of 
CVD (111).  
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1.2.4 Associations between childhood cardiovascular risk factors and end-
organ function in adulthood 
Associations between childhood CV risk factors and adverse end-organ function in adulthood 
have been examined previously in large prospective studies of general populations, such as 
the Muscatine study (112), the Bogalusa Heart Study (9, 113-116), the Cardiovascular Risk in 
Finns Study (117-121), the Childhood Determinants of Adult Health Study (122) and the 
European Youth Heart Study (123). Some of these studies have also been evaluated together 
in reviews and/or meta-analyses (122, 124-126). However, other longitudinal studies also 
exist (127-131). Longitudinal studies following only those with obesity from childhood to 
adulthood are few. Some of the above studies evaluate adverse end-organ function in 
adulthood (near or in middle age), when ageing itself has started to have a crucial role for the 
CV outcome studied, and must be adjusted for. In addition, in most of these longitudinal 
studies, childhood measurements were performed before or at the beginning of the rise of the 
obesity epidemic (128, 130-132), and therefore may not reflect the future risks for today’s 
children with a higher prevalence of overweight and obesity, and exposed to a different 
environment, with for example more fast food which also is more available in different shops 
and supermarkets, and different transportation facilities decreasing the natural level of 
physical activity. 
1.2.4.1 Measures of obesity in childhood 
Childhood BMI increases the risk of risk factors for CVD in young adulthood (133), 
increases cIMT (114, 134), and increases the risk of premature death up to the age of 55 
(131). Childhood obesity is associated with an increased risk of both nonfatal and fatal 
coronary heart disease (CHD) from the age of 25 to the age of 60 (130). Childhood adiposity 
predicts cardiac mass in adulthood (135). In addition, having obesity since childhood is 
associated with LVH in adults (116). Childhood BMI and increased BMI from childhood to 
adulthood predict higher LVM in adulthood, even after adjusting for adult systolic blood 
pressure (SBP) and fasting glucose levels (136). 
1.2.4.2 Blood pressure in childhood 
Childhood SBP predicts arterial stiffness in young adulthood (115). A high SBP in 
adolescence (males only) but not in childhood (males and females) predicted adult brachial 
endothelial dysfunction (119). Childhood hypertension predicts higher cIMT in adulthood if 
the hypertension persists into adulthood (137). The change in adiposity and SBP from 
childhood to adulthood predicted the LVM index in young adulthood (135). 
Blood pressure in childhood is often assessed via in-office blood pressure measurement. 
Longitudinal studies evaluating the association between childhood 24-hour ABPM and adult 
end-organ function seem to be lacking. In hypertensive adults, a non-dipping pattern is 
related to arterial stiffness (138). 
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1.2.4.3 Blood lipids in childhood 
Adult cIMT is predicted by childhood LDL cholesterol (114), APO B and APO A1 (40), and 
total cholesterol (112). Compared with normal levels, high levels of childhood LDL 
cholesterol and triglycerides were associated with increased cIMT in adulthood. This was 
worsened by the presence of increased numbers of non-lipid CV risk factors or MetS (139). 
Childhood APO B and APO A1 also predict brachial endothelial function (40). 
1.2.4.4 Physical activity and cardiorespiratory fitness in childhood 
CRF in adolescence did not predict CVD risk factors in adulthood more accurately than 
childhood measures of body fat (140). Adolescents with a greater decrease in moderate- to 
vigorous-intensity physical activity from adolescence to young adulthood had more 
pronounced arterial stiffness as young adults than those with preserved levels of moderate- to 
vigorous-intensity physical activity (123). Childhood CRF measured at the age of 13 was 
associated with blood pressure in young adulthood, but was not associated at ages 25 and 40. 
The relationship to blood lipids was absent short after the age of 13 at baseline (141). 
1.2.4.5 Metabolic syndrome in childhood 
Childhood and adolescent MetS predicts MetS, high cIMT and T2DM in young adulthood 
(125). MetS in childhood may also predict a higher risk of developing MetS, myocardial 
infarction and stroke in middle age, although longitudinal changes in BMI also affect the 
associations (128). In another study, childhood MetS cluster scores, but not the dichotomous 
MetS, predicted MetS in young adulthood (110). A lower CV risk in adulthood was found 
among those who had lower levels of the variables included in MetS at childhood (142). 
Those categorized as metabolically-healthy obese in childhood were more likely to remain so 
into adulthood, and were hence at a lower risk of CVD (32). 
1.2.4.6 The influence of change in post-childhood BMI  
Some previous studies on the influence of a change in BMI or obesity status on associations 
between childhood CV risk factors and CV outcomes in adulthood indicate that the change 
alters the association if taken into account in the analyses. After adjusting for adult BMI, the 
associations between childhood BMI and both adult blood pressure and cIMT were weakened 
(111). Those at risk of the highest blood pressure in adulthood were those with a lower BMI 
in childhood but overweight in adulthood, suggesting that the change in BMI status might be 
of higher importance than childhood BMI for predicting future CV health (111). Another 
study showed that a higher BMI from childhood to adulthood compared with a normal BMI 
in childhood and non-obese state in adulthood increased the risk of hypertension, T2DM, 
dyslipidaemia, and increased cIMT (124). Associations found between childhood BMI and 
the risk of T2DM, hypertension and CHD are dependent on adult BMI since associations 
were attenuated when adjusting for adult BMI. Longitudinal studies would therefore adjust 
for adult BMI but this is seldom done or studies fail to show associations when adjusting for 
adult BMI (143). Overweight is associated with adverse CV outcomes in adolescence and 
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adulthood if not resolved by this point in time (144). Associations between measures of 
obesity and vascular structure and function were influenced by the tracking of obesity (121). 
Childhood overweight was associated with increased cIMT when participants became obese 
in adulthood, but not if they were overweight (134). 
1.2.4.7 Influence of age at the time of measurement of risk factors 
The age at the time of measurement of CV risk factors in childhood might influence the 
associations with the outcome measures in adulthood. CV risk factors measured before the 
age of 9 were not predictive of adult cIMT as CV risk factors measured after the age of 9 
(145).  
Although there are longitudinal studies of general populations in which the impact of a high 
BMI or the state of obesity are evaluated, long-term follow-up studies of the relationship 
between childhood CV risk factors and end-organ function in young adults who have been 
attending childhood obesity treatment is lacking. To optimise resources within childhood 
obesity treatment, the evaluation of childhood risk factors of importance for future CV risk in 
this specific group is important. A previous study of young Japanese adults previously treated 
for childhood obesity showed a high prevalence of persistent obesity in adulthood and a 
higher prevalence of chronic diseases such as hypertension, dyslipidaemia, T2DM, 
atherosclerosis and stroke among those still having obesity in adulthood. However, the 
follow-up was performed via questionnaire, which is a weakness (146). 
1.2.5 Weight loss and cardiovascular risk factors 
After attending a 1-year intervention program, a weight loss of ≥ 0.5 BMI SDS in children 
with obesity decreased SBP, DBP, LDL cholesterol, triglycerides, and measures of insulin, 
and increased HDL cholesterol (147, 148). One-year lifestyle modifications in adolescents 
with obesity resulted in a decrease of ≥ 0.5 in BMI SDS, and further improvements in 
triglycerides, LDL cholesterol and CRP (149). An effect was also found with a reduction of ≥ 
0.25 in BMI SDS, although it was less pronounced (149). 
Improvement in LVH can be achieved via weight reduction in children and adolescents with 
obesity, but is strengthened by a simultaneous normalization of elevated blood pressure, if 
present (86). A 1-year weight loss intervention in children and adolescents with obesity found 
effects from weight loss on 24-hour ABPM, but no convincing effects on arterial stiffness 
(150). 
In a 1-year outpatient intervention in children with obesity, cIMT was improved after a 
weight loss of 0.5 BMI SDS in parallel with improved CV risk factors such as blood pressure, 
blood lipids, and insulin (151). Among those with a lower decrease or no decrease in BMI 
SDS, no significant improvements in CV risk factors or cIMT were detected (151). 
Weight reduction among children with obesity also improves OSA (152). 
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Gaining weight (111) or having obesity (124) from childhood to adulthood are associated 
with adverse CV risk factors in adulthood. Even though there is convincing evidence that 
weight loss is effective in improving CV risk factors, and that children with obesity who 
become normal weight at adulthood do not have an increased risk of CVD compared to those 
who never had obesity, obesity in childhood and adolescence persist into adulthood at a high 
rate (23). In addition, weight loss has been found to be hard to achieve, especially among 
adolescents with obesity, despite their participation in childhood obesity treatment (153). 
Therefore, approaches other than achieving an adequate weight reduction to acutely improve 
CV risk factors in children and, especially, adolescents with obesity, must be studied.  
1.2.6 Effect of aerobic exercise in childhood on cardiovascular risk factors 
The obesity paradox is considered to be modified by CRF. Subjects with obesity improve 
their CV risk factors or CVD outcomes when they improve their CRF, at least when starting 
from an unfavourable CRF. But when high CRF already exists, increasing the CRF further 
may not modify CV risk factors (154). In addition, exercise did not affect flow-mediated 
dilatation (FMD) among children with already normal vascular function (155). 
In a recent review, exercise interventions among children and adolescents with obesity had an 
effect on weight loss, but there was limited evidence of an effect on CV risk factors (156). 
However, CRF in a general population of children is associated with metabolic risk factors 
(97), and effects have also been demonstrated from physical activity interventions on physical 
fitness and CV risk factors among adolescents with overweight and obesity (157). 
In addition, aerobic exercise without weight loss has improved several CV risk factors in 
children and adolescents with obesity: CRF, HDL cholesterol and FMD (158); abdominal and 
truncal fat (159); inflammatory markers  (160); lipoprotein particle size and cholesterol 
distribution (161); macrovascular and microvascular function, without improvements in CRF 
or whole body insulin sensitivity (162); macrovascular endothelial function (163); and insulin 
resistance (164). Physical activity also has positive effects on components of metabolic 
syndrome in childhood (165). 
One consequence of increased structured exercise in children and adolescents is that total 
physical activity may not increase (166), as per the “ActivityStat hypothesis” (167). The 
“ActivityStat hypothesis” says that overall physical activity is hard to change in individuals, 
despite the introduction of structured exercise sessions. Total physical activity might even 
decrease, as has been seen among adolescents with obesity (168). 
Adolescent CRF seems to not be associated with CV risk factors in adulthood, but indicates 
a relationship with measures of body fat in adulthood (140). However, improved CRF from 
childhood to young adulthood has been found to improve arterial stiffness, but not cIMT 
(127). 
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1.2.6.1 Intensity and frequency of exercise 
Exercise may need to be performed at high intensities in adolescents in order to improve 
vascular function such as FMD (159); low intensities did not improve FMD (155). In 
sedentary adults with obesity, high-intensity exercise was required to improve CRF (169). 
Intensities of around 150 bpm during at least 30 minutes, 3 times a week seem to be sufficient 
to improve insulin sensitivity (164) and FMD (159) in children with obesity. Higher amounts 
of moderate- to vigorous-intensity physical activity among children and adolescents is 
associated with preferable cardiometabolic risk factors, regardless of time spent sedentary 
(170). However, another study in children and adolescents concluded that only vigorous-
intensity physical activity was advantageous (171). 
1.2.6.2 Factors affecting participation and compliance with exercise 
Attitudes towards physical activity appear to have an important effect on participation in 
physical activity. Attitudes towards physical activity are less positive, and rates of 
participation in sports are lower among adolescents with overweight and obesity compared to 
normal-weight adolescents (172). Lack of interest and time have been shown to be a 
hindrance to performing exercise among adolescents with overweight and obesity (173). In a 
study examining what adolescents want in order to become more active, it was shown that 
adolescents with overweight and obesity were less likely to be physically active with friends 
compared with normal-weight adolescents (174). Social support from parents and friends and 
self-efficacy have an impact on physical activity among adolescents (175). The intensity of 
the exercise might also affect compliance through modifying the pleasure of exercise. In adult 
woman with overweight, a small increase in intensity above a self-selected intensity of 
exercise decreased the pleasure of exercise (176). 
1.3 GAPS IN THE KNOWLEDGE WITHIN THE FIELD OF CARDIOVASCULAR 
RISK FACTORS IN CHILDREN AND ADOLESCENTS WITH OBESITY 
Children with various CV risk factors have been found to have endothelial dysfunction. 
Microvascular endothelial dysfunction seems to be a first sign of atherosclerosis. However, 
studies in children, particular those measuring endothelial function in the microvasculature, 
are limited. Studies of microvascular acetylcholine-induced endothelial-dependent 
vasodilatation in children with obesity, without comorbidities, and associations with other 
potential risk factors, are lacking.  
Blunted nocturnal blood pressure dipping, associated with a risk of CVD in adults, is also 
present in adolescents to a surprisingly high degree, but whether this is true for younger 
children as well, and whether there are associations with measures of insulin-glucose 
metabolism or sleep-disordered breathing is unknown. 
In longitudinal studies of the general population, the presence of CV risk factors in childhood 
is associated with adverse CV outcomes in adulthood, but these are probably more affected 
by changes in weight from childhood to adulthood. The long-term effects of childhood CV 
risk factors on CV health in young adults treated for childhood obesity are unknown.  
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Weight reduction improves several obesity-related CV risk factors, but weight loss in 
children and adolescents with obesity is hard to achieve, even when they participate in 
obesity treatment programmes. Aerobic exercise with improved CRF also improves CV risk 
factors in different exercise programme designs. However, children and adolescents with 
obesity are less prone to participate in exercise if it is performed in a group and/or the 
exercise is too inaccessible. Studies to evaluate the performance of individualised aerobic 
exercise with a personal coach close to the school or home of adolescents with obesity in 
order to increase accessibility, as well as the maintenance of exercise, with the goal of 
increasing CRF and affecting CV risk factors, are lacking. 
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2 AIMS 
2.1 OVERALL AIMS 
The main aims of this study are to investigate the following: 
 The prevalence of cardiovascular risk factors in children and adolescents who are in 
childhood obesity treatment.  
 The predictive value of childhood cardiovascular risk factors for early signs of 
cardiovascular end-organ function in young adulthood. 
 The effect of regular supervised individualized aerobic exercise on short- and long-
term cardiorespiratory fitness and associated cardiovascular risk factors. 
2.1.1 Specific aims 
The specific aims of this paper are as follows: 
 To test acetylcholine-induced endothelium-dependent vasodilatation in children with 
obesity but without comorbidities, compared with normal-weight children controls 
(Study I). 
 To analyse associations between vasodilatation and other potential risk factors in 
children with obesity but without comorbidities (Study I). 
 To analyse the prevalence of nocturnal blood pressure dipping among prepubertal and 
early pubertal children with obesity (Study II). 
 To analyse the relationship between dipping and measures of insulin-glucose 
metabolism or sleep-disordered breathing among prepubertal and early pubertal 
children with obesity (Study II). 
 To evaluate if well-established cardiovascular risk factors can be used clinically for 
the early identification of children and adolescents with obesity who are at risk of a 
rapid deterioration in cardiovascular health in young adulthood (Study III). 
 To evaluate if 3 months of regular supervised individualised aerobic exercise can 
increase cardiorespiratory fitness and implement improved long-term 
cardiorespiratory fitness among adolescents in obesity treatment (Study IV). 
 To evaluate the effect of 3 months of regular supervised individualised aerobic 
exercise on cardiovascular risk factors among adolescents in obesity treatment (Study 
IV). 
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3 METHODS 
3.1 ORIGIN OF STUDY POPULATIONS 
The populations included in the studies in this thesis were mainly recruited from the National 
Childhood Obesity Centre in Stockholm, Sweden and the Swedish Childhood Obesity 
Register (BORIS). A summary of the included studies is presented in Table 1. 
3.1.1 The National Childhood Obesity Centre 
It is possible to carry out obesity treatment in various health care settings all over Sweden. 
However, when morbid obesity or complicated obesity with comorbidities are present, 
children and adolescents can be referred to the National Childhood Obesity Centre in 
Stockholm, which was founded in 1997. The main goals of treatment are to involve the 
family, highlight the severity of the disease and focus on lifelong treatment. The treatment 
consists mainly of behavioural treatment regarding diet and physical activity, but may also be 
accompanied by low- and very-low-calorie diets and/or pharmacological treatment when 
necessary. Comprehensive obesity-related physical examinations are performed routinely at 
admission for treatment. During the course of treatment, examinations of importance for the 
treatment of a specific individual are repeated when required. 
3.1.2 The Swedish Childhood Obesity Register  
To be able to follow the treatment of children and adolescents with obesity and evaluate their 
treatment, the nationwide web-based register BarnObesitasRegistret i Sverige (BORIS) was 
started in 2005 (www.e-boris.se). Children attending childhood obesity treatment are 
supposed to be registered in the BORIS register, which can be used for evaluation of 
childhood obesity treatment both regionally and nationally, but also used for clinical research. 
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Table 1. Summary of the studies included in the thesis.     
  Study I Study II Study III Study IV 
Aim 
To test acetylcholine-induced 
endothelium-dependent 
vasodilatation in children with 
obesity without comorbidities, 
compared with normal-weight 
controls, and to analyse 
associations between 
vasodilatation and other potential 
risk factors. 
To investigate the prevalence of 
nocturnal blood pressure dipping 
among obese prepubertal and 
early pubertal children and to 
analyse the relationship between 
dipping and measures of insulin-
glucose metabolism or sleep-
disordered breathing. 
To evaluate if well-established 
cardiovascular risk factors can be 
used clinically to early identify 
children and adolescents with 
obesity at risk of a rapid 
deterioration of cardiovascular 
health in young adulthood. 
To study the effect of three months 
regular supervised individualised 
aerobic exercise on short- and 
long-term cardiorespiratory fitness 
and cardiovascular risk factors 
among adolescents in obesity 
treatment. 
Design 
Retrospective 
Cross sectional 
Observational 
A normal-weight group for 
comparison. 
Retrospective 
Cross sectional 
Observational 
Prospective 
Longitudinal 
Observational 
Prospective 
Longitudinal 
Observational 
Intervention 
Population 
Children with obesity, admitted to 
the National Childhood Obesity 
Centre in Stockholm, Sweden 
between 1996 and 2007. Normal-
weight children for comparison. 
Children with obesity, enrolled to 
the National Childhood Obesity 
Centre in Stockholm, Sweden and 
registered in the BORIS register. 
Young adults who have attended a 
treatment program for severe 
childhood obesity at the National 
Childhood Obesity Centre in 
Stockholm, Sweden and registered 
in the BORIS register. 
Adolescents with obesity attending 
a treatment program at the National 
Childhood Obesity Centre in 
Stockholm, Sweden, the pediatric 
outpatient clinic in Huddinge or the 
pediatric outpatient clinic at 
Södertälje Hospital, Sweden. 
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3.2 STUDY I 
3.2.1 Design and population 
The population in this retrospective cross-sectional study consisted of children with obesity 
admitted to the National Childhood Obesity Centre in Stockholm, Sweden between 1996 and 
2007. Data from 49 healthy Swedish children with normal weight, previously investigated 
with the same apparatus as the children with obesity, were available for comparison (177, 
178). 
3.2.1.1 Inclusion and exclusion criteria 
Sixty-eight children with obesity who had undergone an endothelial functioning test at 
admission to the obesity treatment were included. Exclusion criteria were invalid endothelial 
functioning test, type 2 diabetes (179), hypertension (50) or hyperlipidemia (according to 
accredited laboratory cut-offs). In order to study associations between microvascular 
acetylcholine-induced vasodilatation and obesity-related risk factors and confounders, a 
subgroup of the children with obesity was studied. There was information from biochemical 
analyses of these children, and there was also information about additional obesity-related 
risk factors and confounders within the same time period as the endothelial functioning test 
for most of them. 
3.2.2 Data collection 
Data on microvascular endothelial function (acetylcholine-induced endothelium-dependent 
vasodilatation), anthropometric assessments—weight and height, dual X-ray absorptiometry 
(DXA), 24-hour ABPM, frequently sampled intravenous glucose tolerance test (FSIVGTT), 
submaximal ergometer cycle test, and duration of obesity for the children with obesity were 
extracted from medical records or the BORIS register. Data on microvascular acetylcholine-
induced vasodilatation and descriptive and anthropometric data for the normal-weight 
children (177, 178) were obtained from the authors. Other data included for all children were 
classification of normal weight and obesity (15), and calculated BMI SDS (18). 
3.3 STUDY II 
3.3.1 Design and population 
The population in this retrospective cross-sectional study consisted of children with obesity 
enrolled at the National Childhood Obesity Centre in Stockholm, Sweden, and registered in 
the BORIS register. 
3.3.1.1 Inclusion and exclusion 
This study included 115 prepubertal and early pubertal children for whom information on 
BMI was available, and who had performed a complete 24-hour ABPM at admission to 
obesity treatment. Excluded were subjects lacking data from 24-hour ABPM due to technical 
problems, or poor compliance with the measurement.  
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3.3.2 Data collection 
Data from 24-hour ABPM, echocardiography, polygraph recordings, biochemical variables 
and anthropometric measurements including DXA were obtained from the BORIS register. 
3.4 STUDY III 
3.4.1 Design and population 
The population examined in this longitudinal prospective study was young adults who had 
attended a treatment program for severe childhood obesity at the National Childhood Obesity 
Centre in Stockholm, Sweden and registered in the BORIS register. 
3.4.1.1 Inclusion and exclusion 
In order to be included, subjects had to have information from having performed an 
intravenous frequency sampling glucose tolerance test (not included here) and a 24-hour 
ABPM performed within a reasonable timeframe from each other, a minimum of 5 years; 
these criteria were met by 151 subjects. Exclusion criteria were: bariatric surgery, 
pharmaceutical treatment or diagnoses affecting the ability to participate, or variables 
measured at follow-up. The inclusion process is presented in Figure 1. 
 
 
Figure 1. Flow chart of the inclusion process in Study III. 
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3.4.2 Data collection 
Subjects, now in young adulthood, who met the inclusion criteria were identified using the 
BORIS register. They were informed about the study via mail and telephone. Those who 
fulfilled the exclusion criteria were invited to participate in the study. In young adulthood, the 
examinations were performed over 2 days at the Karolinska University Hospital in Huddinge 
after an overnight fast each day. Measurements performed both in childhood and in young 
adulthood were anthropometry, 24-hour ABPM, echocardiography, biochemical analyses, 
and submaximal bicycle test. In addition, the presence of MetS was determined. In addition, 
in young adulthood, microvascular acetylcholine-induced endothelium-dependent 
vasodilatation, pulse wave analysis, and ultrasonography of the carotid arteries were 
measured. In childhood, information on pubertal status also was collected. Data on 
measurements performed in childhood were collected from medical records and/or the 
BORIS register.  
3.5 STUDY IV 
The original aim of this randomised controlled clinical intervention was to study the impact 
of aerobic exercise or metformin therapy on nocturnal blood pressure and related risk factors 
for CVD in adolescents with obesity. 
The design had three groups: the first was treated with a daily dose of 2000 mg of Metformin 
over 12 months; the second group performed regular individualised aerobic exercise 3 times a 
week over 12 months, led by a personal coach during the first 3 months; the third was a 
control group.  
Unfortunately, the recruitment process turned out to be more difficult than expected. In 
addition, the dropout rate, mainly among the controls, was large soon after randomisation. It 
was decided to terminate the study, and primarily evaluate those who performed the aerobic 
exercise, which is Study IV in this thesis. 
3.5.1 Design and population 
This longitudinal, prospective intervention study was performed among adolescents with 
obesity attending a treatment program at the National Childhood Obesity Centre in 
Stockholm, Sweden, the outpatient clinic in Huddinge, or the outpatient clinic at Södertälje 
Hospital, both in Sweden. 
3.5.1.1 Inclusion and exclusion 
Inclusion criteria were adolescents with obesity (15) aged 13–19 who had recently completed 
a 24-hour ABPM. Excluded were those with diagnoses or treatments affecting the studied 
variables; medical treatment contraindicated for the original study aim; and mental or 
physical conditions preventing sufficient compliance with the original study protocol. 
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3.5.2 Data collection 
Physiological examinations were performed at baseline, after the 3-month exercise period 
with the personal coach, and 9 months after the coaching period. The physiological 
examinations were performed over 2 days at the Karolinska University Hospital in Huddinge 
after an overnight fast each day. The examinations consisted of anthropometry including 
DXA, a submaximal bicycle test, biochemical analyses, an oral glucose tolerance test, 24-
hour ABPM, pulse wave analyses, microvascular acetylcholine-induced endothelium-
dependent vasodilatation, accelerometry, a questionnaire on health-related quality of life and 
pubertal status. In addition, the presence of MetS was determined. 
Subjects followed their ordinary plans for obesity treatment during the study. 
3.5.3 Aerobic exercise intervention 
Appropriate, individualised, moderate- to high-intensity aerobic exercise was chosen by the 
subject and the personal coach together in Study IV. Both type of exercise and location were 
carefully chosen to increase the chances of getting the adolescent to attend, perform and also 
continue with the exercise after the supervised period. To make the exercise as accessible as 
possible for the adolescent, the exercise was made available in a location near the subject’s 
home or school. The exercise was performed for 45 minutes, 3 times per week (159) under 
the supervision of the personal coach during the first 3 months. During this time, the subject 
wore a heart rate monitor (Polar RS400, Polar Electro Sverige AB, Bromma, Sweden) to 
ensure sufficient intensity at a mean heart rate of 150 beats per minute (bpm) for at least 30 
minutes (164). During the following 3 months, the subject performed aerobic exercise at the 
same intensity and frequency, but without the coach; instead, the personal coach or someone 
from the research team made weekly contact with the subject for support. During the final 6 
months, the subject performed aerobic exercise without any support. The subject was 
instructed to fill out an exercise diary after each exercise session during the entire year, and 
mail it monthly to the research team to monitor exercise compliance. Those with a 
compliance of < 75% were excluded from statistical analyses. 
3.6 MEASUREMENTS 
A summary of measurements and variables included in the studies is presented in Table 2. All 
examinations were performed by trained or specialised staff either in the research group, at 
the National Childhood Obesity Centre in Stockholm, or at specialised clinics at the 
Karolinska University Hospital in Huddinge, depending on which examination was 
performed. 
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Table 2. Overview of measurements and related variables included in each study of this thesis.  
Variable 
Study 
I 
Study 
II 
Study 
III 
Study 
IV 
Age x x x x 
Sex x x x x 
Pubertal status   x x x 
Weight x x x x 
Height x x x x 
Waist circumference       x 
BMI     x x 
BMI SDS, Karlberg et al. (18) x       
BMI SDS, Roland-Cachera et al. (17)   x     
BMI SDS, Cole et al. (16)     x x 
delta BMI SDS, Cole et al. (16)     x x 
Classification of BMI (15)     x   
Duration of obesity x       
Time to follow-up     x   
Time in treatment     x   
24-hour Ambulatory Blood Pressure Monitoring x x x x 
24-h SBP x x     
24-h DBP x x     
Daytime SBP x x x x 
Daytime DBP x x x x 
Night-time SBP x x x x 
Night-time DBP x x x x 
SBP dipping x x x x 
DBP dipping x x x x 
Acetylcholine-induced endothelium-dependent vasodilatation x   x x 
Basal Perfusion x   x   
Peak perfusion x   x x 
Echocardiography   x x   
Left Ventricular Mass     x   
Left Ventricular Mass Index   x x   
Ultrasonography     x   
 Carotid Intima-Media Thickness     x   
Pulse Wave Analysis     x x 
Arterial stiffness (AIx@HR75)     x x 
Intravenous frequent sampling glucose tolerance test x x     
Acute insulin responsiveness to glucose x x     
Insulin sensitivity index x x     
Glucose effectiveness x x     
Disposition index x x     
The Homeostasis model assessment index x x     
Oral glucose tolerance test       x 
2-hour glucose       x 
2-hour insulin       x 
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Table 2. Overview of measurements and related variables included in each study of this thesis. 
Continued. 
Variable Study I Study II Study III Study IV 
Dual X-ray Absorptiometry   x   x 
Body fat per cent   x   x 
Lean body mass per cent       x 
Android fat per cent       x 
Gynoid fat per cent       x 
Abdominal fat per cent   x     
Submaximal bicycle test x   x x 
Absolute maximal oxygen consumption     x x 
Relative maximal oxygen consumption x   x x 
Polygraph recording   x     
Apnoea-hypopnoea index   x     
Oxygen desaturation index   x     
Lowest oxygen saturation   x     
Biochemical variables x x x x 
Glycosylated hemoglobin A1c x x   x 
Glucose x x   x 
Insulin x x   x 
HDL cholesterol x   x   
LDL cholesterol x   x   
LDL/HDL ratio     x x 
Total cholesterol x   x x 
Triglycerides x   x x 
hs-CRP x     x 
Apo B       x 
Apo A1       x 
Apo B/Apo A1 ratio       x 
Metabolic syndrome score     x x 
Smoking prevalence     x   
Quality of life questionnaire       x 
Physical Health score       x 
Psychosocial Health score       x 
Total score       x 
Accelerometry       x 
Mean counts per minute/day       x 
Minutes/day < 1.5 METs       x 
Minutes/day > 3 METs       x 
Minutes/day > 6 METs       x 
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3.6.1 Anthropometry 
Weight and height were measured with a calibrated wall-mounted scale to the nearest 0.1 kg 
and 0.1 cm, respectively. BMI was calculated, and was classified in children and adolescents 
by age and sex specific cut-offs (15) corresponding to the adult cut-offs for normal weight, 
overweight, obesity and severe obesity, defined as 18.5–24.9 kg/m2, 25.0–29.9 kg/m2, 30.0–
34.9 kg/m
2 and ≥ 35.0 kg/m2, respectively.  
In order to compare BMI between groups, ages or sexes, and to follow BMI over time, BMI 
SDS was calculated according to Karlberg et al. in Study I (18), Roland-Cachera et al. in 
Study II, and the International Obesity Task Force (IOTF) in Studies III and IV (16). In order 
to follow BMI from childhood to young adulthood in Study III, BMI SDS was calculated for 
the young adults also, and it was estimated that all were 18 years old at follow-up. 
Body composition and fat distribution were studied via DXA in Study II (Lunar Prodigy, 
software version 8) and Study IV (iDXA). Waist circumference was measured with a tape 
measure to the nearest 0.5 cm (Study IV). 
3.6.2 Biochemical analyses 
Fasting venous blood samples was collected in order to measure blood lipids (Studies I, III, 
and IV), hs-CRP (Studies I and IV), glycosylated hemoglobin A1c (HbA1c) (Studies I and 
II), insulin and glucose (Studies I, II and IV) were drawn in the morning after an overnight 
fast starting at midnight. Homeostasis model assessment (HOMA) was calculated based on 
fasting insulin and glucose (180) in Studies I and II. Biochemical analyses were performed in 
the laboratory at Karolinska University Hospital in Huddinge, according to accredited 
standard procedures present at the time the blood samples were drawn and analysed in each 
study.  
Reference data for abnormal levels differs between studies. The reference from the expert 
panel on integrated guidelines for cardiovascular health and risk reduction in children and 
adolescents was used for children and adolescents (39) in Studies III and IV, and the Third 
Report of the National Cholesterol Education Program was used for adults in Study III (181). 
References for variables (Studies III and IV) not included in these reports came from the 
chemical laboratory at Karolinska University Hospital. 
3.6.3 Metabolic syndrome score 
The MetS score was calculated according to Zimmet et al. in Study IV and at baseline in 
Study III (182). At follow-up in Study III, Alberti et al. was used since the criteria are 
different for adults (183). The five possible risk factors included in the concept of MetS are 
obesity or elevated waist circumference, lowered HDL cholesterol, elevated fasting glucose, 
casual blood pressure, and triglycerides. 
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3.6.4 24-hour ambulatory blood pressure monitoring 
The 24-hour ABPM was measured in all studies using the Space Labs 90 207/90 217 
apparatus (Space Labs, Workingham, UK) to evaluate circadian variations in blood pressure. 
Overall, the consensus guidelines for 24-hour ABPM were followed (184). A cuff of 
appropriate size was placed on the upper non-dominant arm and connected to a small 
apparatus attached to a belt around the waist. Subjects were instructed to live normally as 
much as possible, but not to move the arm during readings. The participants were told to fill 
in a diary with wake and sleep times and other events possibly affecting the 24-hour 
measurement. If required, the standard daytime (8 a.m. to 8 p.m.) and night-time (12 p.m. to 6 
a.m.) were adjusted to conform to what was reported in the diary. If possible, the night-time 
was offset to still include 6 hours of sleep. A minimum of 1 hour after bedtime and 
awakening was excluded from sleep time and waking hours, respectively, if within or very 
close to the standard night-time and daytime, to minimize incorrect night-time and daytime 
mean values. The aim was to have a minimum of 70% of possible readings during daytime 
and night-time respectively for a measure to be valid (184). However at baseline in Study III, 
several of the measurements were missing blood pressure readings, and when necessary, the 
cut-off for the percentage of valid readings was lowered to 50%. At follow-up in Study III, 
the cut-off was also lowered to 50% in some measurements. 
Dipping is a measure of the per cent difference between daytime blood pressure and night-
time blood pressure; if the dip is less than 10%—a commonly-used and widely-accepted cut-
off for an absent decrease of nocturnal blood pressure—this is referred to as non-dipping. 
For determining hypertension from 24-hour ABPM in children, the reference from Wühl et 
al. (50) was used in Studies I and II, and the reference from Lurbe et al. (51) in Study III. 
3.6.5 Submaximal bicycle test 
Submaximal tests were performed according to Åstrand (185) to estimate CRF as absolute 
and relative maximal volumes of oxygen consumption (VO2 max). The subject is supposed to 
cycle for 6 minutes at an appropriate workload in order to reach a steady state in heart rate 
between minutes 5 and 6. At the end of every minute, the subject estimated the exertion on 
the Borg Rated Perceived Exertion (RPE) scale (186) to ensure and confirm the right 
workload had been chosen or adjust it at the beginning of the test and restart. Heart rate and 
level on the Borg RPE scale were noted every minute. The tests were performed on two 
different bicycle models in the included studies. A mechanically-braked bicycle (Monark, 
864, Varberg, Sweden) was used in Study I, at baseline in Study III, and in some of the tests 
in young adulthood in Study III, where the method has been described previously (187). In 
most of the tests in young adulthood in Study III and all tests in Study IV, an electronically-
braked bicycle (Siemens Elma, Rodby elektronik AB) was used. Compared to the 
mechanically-braked bicycle, where the frequency of pedalling is important for the workload, 
the frequency of pedalling is unimportant when using the electronically-braked bicycle, since 
the bicycle adjusts its own resistance in order to provide the selected workload. In order to 
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make the results of the tests performed with the different bicycles comparable, maximum 
VO2 estimates were made. In Study III, the degree of CRF was classified according to 
Anderson et al. (188).  
3.6.6 Accelerometry 
The Actiwatch
®
 accelerometer (AW, Model 4; Cambridge Neurotechnology Ltd, Cambridge, 
United Kingdom) was used to measure physical activity (PA) in Study IV, and worn as a 
watch on the non-dominant arm for 1 week. It was only removed for bathing. A minimum of 
3 valid days (189), including 1 weekend day, were required to produce a valid measurement. 
PA is presented as mean counts per minute (cpm) of total days recorded, time spent in 
sedentary PA (< 1.5 METs = < 320 cpm), time spent in moderate to vigorous intensity PA (> 
3 METs = > 1048 cpm), and time spent in vigorous intensity PA (> 6 METs = > 1624 cpm) 
(190). 
3.6.7 Frequently sampled intravenous glucose tolerance test 
With FSIVGTT (191) and minimal model analysis (192) it is possible to evaluate several 
aspects of insulin and glucose metabolism: insulin sensitivity (how well insulin enhances 
glucose disposal and inhibits endogenous glucose production); glucose effectiveness 
(glucose-mediated glucose disposal); acute insulin responsiveness (AIR) to glucose 
(endogenous insulin secretion); and disposition index (AIR x insulin sensitivity). Details of 
the protocol used in Studies I and II are described elsewhere (60). After an overnight fast 
starting at midnight, a peripheral intravenous catheter was inserted in each arm. Fasting 
insulin and glucose were drawn before the glucose was injected over the course of 1 minute. 
The intravenous dose of insulin was given 20 minutes after the glucose injection. Glucose and 
insulin blood samples were drawn at specific time points after the glucose was injected and 
until the examination finished 3 hours later. 
3.6.8 Oral glucose tolerance test 
An extended oral glucose tolerance test (OGTT) was used to determine glucose tolerance 
after oral intake of 75 g of glucose per kilogram of body weight in Study IV (193). After an 
overnight fast, venous blood samples of glucose and insulin were drawn 5 minutes before and 
again just before the oral glucose load was given. Blood sampling continued every 30 
minutes until 120 minutes after the glucose load was given. The last glucose sample was 
taken to determine glucose tolerance (179). 
3.6.9 Acetylcholine-induced endothelium-dependent vasodilatation 
In Studies I, III and IV, acetylcholine chloride was transferred with a weak anodal current 
through the left dorsal hand skin using a micropharmacology system, iontophoresis, to induce 
endothelium-dependent vasodilatation. This was repeated 6 times at 1 minute 20 second 
intervals. Laser Doppler flowmetry was used to measure endothelial function as perfusion in 
the microvasculature after the administration of acetylcholine using iontophoresis. The laser 
Doppler signal, expressed as perfusion units (PU), is proportional to the number and velocity 
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of moving blood cells in the skin. If movement artefacts were within the perfusion change 
area for one dose, that value was excluded from the measurement; however, a maximum of 
one excluded value at each valid measurement was accepted. Basal perfusion ≥ 15 PU was a 
criterion for exclusion according to the manufacturer’s instructions. The perfusion after the 
sixth dose was used as the peak (maximum) perfusion. Details of the methodology and the 
performance have been described elsewhere (177). 
3.6.10 Pulse wave analysis 
Pulse wave analysis (194) measures systemic arterial stiffness; it was performed with the 
SphygmoCor applanation tonometer device (AtCor Medical, Sydney, Australia) placed at the 
radial artery of the non-dominant arm (almost exclusively the left arm) to gently compress the 
artery against the radius bone. The participants had fasted and refrained from exercise and 
smoking overnight, and rested in a supine position in a quiet and temperature-controlled room 
for at least 20 minutes prior to the examination. Three sequential systolic and diastolic blood 
pressures were measured with an Omron M6 Comfort device (Omron Healthcare Europe 
B.V. Hoofddorp, The Netherlands) on the same arm as the pulse wave analysis and entered 
into the software to be included in the software calibration of the radial waveform. Blood 
pressure was measured every 5 minutes until the required number of measurements with 
good quality control (according to the manufacturer’s guidelines) had been captured. 
A general transfer function in the software converted the radial pressure waveform into an 
aortic pressure waveform (195). The Augmentation Index (AIx) standardized for a heart rate 
of 75 (AIx@HR75) (units in per cent) is a measure of arterial stiffness why written as arterial 
stiffness in this thesis. Only the two closest measurements of the three obtained were used, 
provided they passed the quality control and the AIx@HR75 did not differ more than 4% 
between the measurements (196). 
3.6.11 Echocardiography 
Two- dimensional echocardiography was performed at an accredited laboratory in Studies II 
and III according to established standards (197, 198). LVM was calculated using the 
Devereux equation (199). To account for differences in body size, the LVM index was 
calculated by dividing LVM in grams by the 2.7
th
 power of height (g/m
-2.7
), and was used as a 
measure of cardiac structure (200). In Study III, different references for adverse levels were 
used in childhood (201) and adulthood (197). 
3.6.12 Ultrasonography of the carotid arteries 
The ultrasonography in Study III was performed in a supine position on the left and right 
common carotid arteries (CCA) to measure cIMT (78). Three ultrasound images were taken 
in systole on the right and left CCAs; however, only the image in which the intima-media 
complex of the far wall was clearest was used for analysis. A mean value of the right and left 
cIMT was calculated. The reference from Engelen et al. was used for elevated cIMT levels, in 
which the 75
th
 percentile was used for indication of increased risk of CVD (202). 
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3.6.13 Polygraph recordings 
Sleep-disordered breathing (apnoea-hypopnoea index ≥ 1.5), oxygen desaturation index (the 
average number of desaturation dips per hour of sleep) and the lowest oxygen saturation were 
determined after in-hospital overnight sleep polygraph recordings sampled by the Micro 
Digitrapper SAS (Synectics Medical AB, Stockholm, Sweden) according to the hospitals 
standard protocol in Study II.  
3.6.14 Pubertal status 
Pubertal stage (genital and pubic hair development) (37) was examined in Studies II and IV. 
Pubertal stage one is considered prepubertal, stages two and three early pubertal, and four and 
five late pubertal. 
3.6.15 Health-related quality of life 
The Pediatric Quality of Life Inventory version 4.0 for teens, ages 13–18, was used to assess 
health-related quality of life (203) in Study IV. The questionnaire was composed of 23 items 
comprising four dimensions: physical functioning, emotional functioning, social functioning 
and school functioning. The final score was presented as a psychosocial health summary 
score (including emotional, social, and school functioning scales), a physical health summary 
score (including the physical functioning scale), and a total score. 
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3.7 STATISTICAL METHODS 
The STATISTICA 10 data analysis software system, StatSoft, Inc. (www.statsoft.com), was 
used in Studies I and II for statistical analyses. In Studies III and IV, statistical analyses were 
performed with Statistical Package for Social Sciences (SPSS) version 22. A summary of 
statistical methods used in the studies is presented in Table 3. 
 
Table 3. Summary of statistical methods. 
  Study I Study II Study III Study IV 
Descriptive statistics x x x x 
Student´s t-test x x   x 
Mann-Whitney U-test   x     
Paired sample t-test       x 
Non-parametric related sample test       x 
Linear regression     x   
ANOVA   x     
ANCOVA x x x   
Chi-square test x x x   
McNemar’s test     x   
 
3.8 ETHICAL APPOVAL 
All ethical approvals were granted by the Stockholm Regional Ethical Review Board. 
 Study I dnr; 2010//805-31/2. 
 Study II dnr; 2005/1213-31/2 for the BORIS register, from which data was obtained. 
 Study III dnr; 2010/1089-31/1 and 2011/2074-32. 
 Study IV dnr; 2007/1031-31/2 ; 2009/73-32 and 2010/565-32. 
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4 RESULTS 
Characteristics of subjects included in all studies are presented in Table 4. 
 
 
Table 4. Characteristics of included subjects.           
  Study I Study II Study III Study IV   
            
Exercise 
group 
Non-exercise 
group 
  
Normal-weight 
children 
Extensively 
investigated 
children with 
obesity 
Prepubertal and 
early pubertal 
children with 
obesity Childhood 
Young 
adulthood 
Before 
supervised 
exercise   
  Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) Mean (±SD) 
Women/men (n) 36/8 12/25 33/76 25/24 ˗˗˗ 5/3 5/4 
Age (years) 13.7 (3.7) 14.0 (2.3) 10.4 (1.7) 13.8 (2.3) 23.4 (3.0) 15.1 (1.2) 14.7 (1.4) 
Weight (kg) 45.7 (14.0) 102. 3 (27.1) 73.1 (15.9) 95.0 (22.6) 119.0 (29.6) 99.9 (15.0) 99.1 (21.1) 
Height (m) 1.55 (0.15) 1.67 (0.12) 1.51 (0.11) 1.65 (0.11) 1.74 (0.10) 1.68 (0.07) 1.67 (0.09) 
BMI SDS 0.9 (1.4) 3.8 (0.6) 6.2 (1.6) 3.0 (0.4) 3.0 (0.9) 2.9 (0.5) 3.0 (0.5) 
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4.1 CARDIOVASCULAR RISK FACTORS IN CHILDHOOD AND CHANGE TO 
YOUNG ADULTHOOD 
An overview of prevalences of CV risk factors in childhood and young adulthood are shown 
in Figure 2.  
 
Figure 2. Prevalences of cardiovascular risk factors in childhood and young adulthood. P-values 
indicate statistically significant changes in prevalence from childhood to young adulthood among 
those with data at both time points (n = 20–48). 
 
4.1.1 Dyslipidemia (Study III) 
High total cholesterol and LDL cholesterol were both present in about 40% of subjects in 
childhood, and high triglycerides were present in as many as 70% in childhood; all 
prevalences, however, were significantly lower in young adulthood (p = 0.00–0.03). The 
prevalence of high triglycerides was resolved in about 80% of subjects, and high LDL 
cholesterol was totally resolved in young adulthood. For those with low HDL cholesterol in 
childhood, about 50% saw a resolution in young adulthood, however a 15% onset of low 
HDL cholesterol levels was found in young adulthood resulting in a non-significant change 
(p = 0.39). HDL cholesterol and LDL cholesterol tracked into young adulthood, although low 
to moderate (r = 0.35 and r = 0.44, respectively, with p = 0.02 for both). Total cholesterol 
carried into young adulthood at high rates (r = 0.75 and p < 0.01). Triglycerides and the 
LDL/HDL ratio did not track into young adulthood (p = 0.05 for both).  
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4.1.2 Hypertension (Study III) 
The low prevalence of night-time hypertension present in childhood did not change 
statistically in young adulthood (p = 0.63). The prevalence of daytime hypertension increased 
from zero in childhood to 24 % in young adulthood (p = 0.02). Daytime SBP tracked into 
young adulthood (r = 0.56, p < 0.01), but this was not the case for other measures of daytime 
or night-time BP (p = 0.17–0.46). 
4.1.3 Non-dipping (Studies II and III) 
SBP and DBP non-dipping were present at about 40% and 17% in childhood, respectively. 
Prevalences did not differ between pre- and early pubertal children (p = 0.91 and p = 0.25, 
respectively; Studies II and III). Non-dipping resolved to 75% in young adulthood (p < 0.01; 
Study III). SBP dipping tracked into young adulthood (r = 0.43, p = 0.03). 
4.1.3.1 Associations with non-dipping in childhood obesity (Study II) 
BMI SDS, sex, and pubertal status were not associated with SBP or DBP dipping (p = 0.1–
0.8); nor were measures of insulin and glucose metabolism (adjusted for BMI SDS, sex, and 
pubertal status; p = 0.3–1.0) or measures of obstructive sleep-disordered breathing (p = 0.4–
0.7).  
4.1.4 Microvascular endothelial dysfunction (Study I) 
Compared with normal-weight children, microvascular endothelial function was 33% lower 
among children with obesity (p < 0.01). In addition, the change over time in vasodilatation 
from doses 1 to 6 was lower and slower for the children with obesity (adjusted for basal 
perfusion) (Figure 3).  
 34 
 
Figure 3. Dose-response curve after acetylcholine-induced endothelium-dependent vasodilatation in 
normal-weight children and children with obesity. 
 
4.1.4.1 Associations with microvascular endothelial function in childhood obesity 
Duration of obesity was positively associated with microvascular endothelial function (p = 
0.03). Sex, age, BMI SDS, measures of insulin and glucose metabolism, hr-CRP, blood 
lipids, measures of blood pressure (including dipping) and CRF were not associated with 
microvascular endothelial function (p = 0.10–0.86). 
4.1.5 Left ventricular mass hypertrophy (Studies II and III) 
The prevalence of increased LVM index was stable at about 20% from childhood to young 
adulthood (p = 1.00; Study III). There was no tracking of LVM index into young adulthood 
(p = 0.16). 
4.1.5.1 Associations with left ventricular mass index in childhood obesity (Study II) 
BMI SDS was positively associated with LVM index (adjusted for sex, pubertal status and 
measures of SBP and DBP; p < 0.001). Measures of blood pressure (including dipping), 
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insulin and glucose metabolism and sleep-disordered breathing (adjusted for BMI SDS, sex 
and pubertal status) were not associated with LVM index (p = 0.2–1.0). 
4.1.6 Low cardiorespiratory fitness (Study III) 
The prevalences of low absolute and relative CRF were stable at levels of about 40%–60% 
and 80% (respectively) into young adulthood (p = 0.12 and p = 0.22, respectively). There was 
both high remission and onset of low absolute CRF in young adulthood. Relative CRF 
tracked into young adulthood (r = 0.47, p = 0.01), but absolute CRF did not (p = 0.07). 
4.1.7 Metabolic syndrome (Study III) 
The presence of MetS was stable at about 30% from childhood to young adulthood (p = 
0.96), although both remissions and onset of MetS were observed; however, no tracking was 
found (p = 0.88). 
4.2 PREDICTION OF MARKERS OF END-ORGAN FUNCTION IN YOUNG 
ADULTHOOD FROM CHILDHOOD CARDIOVASCULAR RISK FACTORS 
(STUDY III) 
In young adults who had been in childhood obesity treatment, higher childhood triglycerides 
(p = 0.02), total cholesterol (p < 0.01) and daytime SBP (p = 0.04) predicted a higher cIMT 
adjusted for sex and change in BMI SDS. No other adverse effects on cIMT, LVM index, 
microvascular endothelial function, or arterial stiffness were found in young adulthood based 
on relevant childhood CV risk factors (all p ≥ 0.05). 
4.3 THE EFFECT OF 3 MONTHS OF REGULAR SUPERVISED AEROBIC 
EXERCISE ON ADOLESCENTS IN OBESITY TREATMENT (STUDY IV) 
4.3.1 Short- and long-term cardiorespiratory fitness  
Mean values of absolute and relative CRF at each time of measurement in the exercise and 
non-exercise group during the study are shown in Table 5. Absolute and relative CRF 
improved during 3 months (short-term CRF) of supervised aerobic exercise (p = 0.01 for 
both), and also improved compared to the non-exercise group (p = 0.01 for both the 
difference in change in absolute CRF and relative CRF between groups). Absolute and 
relative CRF (p = 0.75 and p = 0.63, respectively) did not change in the non-exercise group. 
Absolute and relative CRF were not further improved 9 months after the end of the 3 months 
of supervised aerobic exercise (long-term CRF), but returned to about the levels present prior 
to the supervised exercise (p = 0.04 and p = 0.03, respectively). The impairment of absolute 
CRF (p = 0.04) was different compared to the non-exercise group, but not relative CRF (p = 
0.07). Absolute and relative CRF in the non-exercise group did not change during these 9 
months (p = 0.50 and p = 0.94, respectively). 
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Table 5. Cardiorespiratory fitness in those who performed supervised aerobic exercise compared with 
a non-exercise group. 
  
Exercise 
group 
Non-
exercise 
group 
Exercise 
group 
Non-
exercise 
group 
Exercise 
group 
Non-
exercise 
group 
  
Before 
supervised 
exercise 
  After 3 
months of 
supervised 
exercise 
  Nine 
months 
after the 
supervised 
exercise 
  
  Mean (± SD) Mean (± SD) Mean (± SD) Mean (± SD) Mean (± SD) Mean (± SD) 
Absolute CRF 
(L/Minute) 3.3 (0.7) 2.8 (0.6) 4.0 (0.8) 2.7 (0.5) 3.4 (0.9) 2.8 (0.6) 
Relative CRF 
(ml/kg*minute) 34.5 (12.1) 29.2 (8.1) 40.5 (11.9) 28.3 (7.4) 31.3 (10.1) 28.4 (8.4) 
 
4.3.2 Cardiovascular risk factors 
No statistically significant effect on CV risk factors was found after the 3 months of 
supervised aerobic exercise (all p ≥ 0.05). However, after the 3 months of supervised aerobic 
exercise, a total remission of MetS was observed in the 2 adolescents with MetS at baseline. 
Nine months after the supervised period ended, no statistically significant favourable CV 
effect was found (all p ≥ 0.05) with the exception of improvements in arterial stiffness. 
Arterial stiffness improved and elevated by 16 units during the 9 months after the supervised 
period ended (p = 0.03). 
  37 
5 DISCUSSION 
5.1 MAIN FINDINGS 
This thesis highlights the presence of CV risk factors that accompany childhood obesity, 
and evaluates important CV risk factors in childhood for the prediction of early signs of 
end-organ dysfunction in young adulthood in order to provide clinicians with factors to 
focus on during childhood obesity treatment to improve future CV health. Further, this 
thesis addresses supervised individualised aerobic exercise as a complement to childhood 
obesity treatment for improving CRF and subsequent CV health in adolescents with 
obesity. 
Study I showed that microvascular endothelium-dependent vasodilatory response to 
acetylcholine was 33% lower among children with obesity compared to normal-weight 
children. Microvascular endothelial function seemed less affected among those who had 
been obese for a longer time. No associations were found with CRF, 24-hour ABPM, 
inflammation, or insulin/glucose metabolism. 
In Study II, a 42% prevalence of systolic non-dipping was found among prepubertal and 
early pubertal children with severe obesity. Dipping was not associated with measures of 
insulin-glucose metabolism after adjustments for BMI-SDS, sex, and pubertal status or 
between dipping and measures of sleep-disordered breathing. 
In Study III, certain childhood CV risk factors—high total cholesterol, high triglycerides 
and high daytime SBP—predicted high cIMT, independent of sex, change in BMI SDS at 
adulthood, and smoking habits at adulthood in young adults who had previously attended 
childhood obesity treatment. The strongest tracking of CV risk factors from childhood to 
adulthood was found in diastolic BP and total cholesterol. Several of the prevalences of CV 
risk factors at childhood were lower in adulthood, despite a high persistence of severe 
obesity. Increased cIMT and low CRF were highly prevalent in young adulthood, however. 
Study IV showed that regular supervised individualised aerobic exercise for 3 months was 
sufficient to improve short-term CRF among adolescents in obesity treatment, but not to 
implement sustained aerobic exercise habits in order to maintain long-term CRF. The 
supervised exercise did not improve CV risk factors during the 3-month coaching period or 
during the following 9 months without the coach, except for improvements in arterial 
stiffness during the last 9 months. 
5.2 ACETYLCHOLINE-INDUCED ENDOTHELIUM-DEPENDENT 
VASODILATATION IN CHILDREN WITH OBESITY 
In children and adolescents with obesity, microvascular endothelial function is much less 
studied than macrovascular endothelial function (72). Endothelial function can be determined 
by assessing vasodilatation by measuring the response to increased blood flow after occlusion 
of the vessel, or by stimulating the endogenous release of nitric oxide from the endothelium 
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using local administration of drugs such as acetylcholine. The latter method is the only non-
invasive method of selectively stimulating endothelium-dependent vasodilatation. Non-
invasive flow-mediated dilatation (FMD) is considered to be the gold standard method for 
measuring endothelial function, but is commonly used at the macrovascular brachial artery 
site. Microvascular endothelial function in children can be measured non-invasively in the 
peripheral cutaneous microvasculature. In any case, these methods are correlated to each 
other (204) and hence the acetylcholine-induced endothelium-dependent vasodilatation can 
be used as a measure of endothelial function in the microvasculature. More discomfort might 
be experienced by children when occlusion is used, whereas acetylcholine-induced 
vasodilation does not hurt; because of this, use of the latter method in children seemed more 
suitable (72). In addition, this method is reproducible (205), easy to use, quick, and operator 
independent.  
Few previously published studies of microvascular endothelial function in children with 
obesity used acetylcholine-induced vasodilatation for assessment (206, 207), though some 
used post-occlusive reactive hyperemia (208-212). Some of the previous studies were 
performed in hypertensive children with obesity (207) or normal-weight children with 
abnormal glucose tolerance or T2DM (206). Impaired microvascular endothelial function 
among children with obesity but without comorbidities compared to normal-weight children 
in Study I was in line with other studies that mostly used different vascular provocation 
methods (207-210, 212). Worsened acetylcholine-induced vasodilatation has also been seen 
among normal-weight children with a higher body fat percentage or a higher 2-hour post-
feeding glucose level using the same method as in Study I (206). 
The duration of obesity at the time of measurement, although not often mentioned in studies 
of obesity, seems to play a role in the presence of comorbidities such as the microvascular 
endothelial dysfunction found in Study I. This relationship has also been noted in a previous 
study of endothelial function among normal-weight children (208). Lower levels of 
endothelial progenitor cells have been detected in adult obesity (213) and the insulin 
resistance state (214), and have been associated with lower brachial endothelial function 
(215). Circulating endothelial progenitor cells in the bloodstream mature into active 
endothelial progenitor cells on demand, and hence repair the damaged endothelium.  
One hypothesis might be that the endothelial progenitor cells have not yet been fully 
activated for repairing the endothelium in subjects having obesity for only a short time. Later, 
the repair process may be stabilized and maintained, and therefore less impaired endothelial 
function is present among those with a longer duration of obesity. But in addition, depending 
on the age at onset of obesity, this adaptation/up-regulation of repair might not be as 
pronounced as in childhood. After the age of 20 years, adults have lower levels of circulating 
progenitor cells than children (216), and if they become obese, their bodies might not be able 
to maintain the same level of repair. This is probably only one of several explanations of the 
relationship between endothelial function and the duration of obesity. 
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Further, children with obesity who were included in the analyses of associations between 
acetylcholine-induced vasodilatation and other potential risk factors may have been healthier 
than those excluded because of missing data in the extended clinical investigation. Those 
included had lower BMI SDS, which may have contributed to the absence of associations 
between acetylcholine-induced vasodilatation and measures of insulin and glucose 
metabolism, 24-hour ABPM, CRF, inflammation, and blood lipids.  
Reference values for impaired acetylcholine-induced vasodilatation related to the future risk 
of CVD are not available, and hence comparison with normal-weight subjects was the natural 
choice to evaluate whether impairment was present. 
5.3 NOCTURNAL BLOOD PRESSURE DIPPING AMONG PREPUBERTAL AND 
EARLY PUBERTAL CHILDREN WITH OBESITY 
24-hour ABPM is preferable to in-office blood pressure measurement when measuring blood 
pressure in children and adolescents, since they are mobile and their blood pressure fluctuates 
with their movements not only during waking hours, but also during sleep. With ABPM, 
short-term and 24-hour blood pressure are recorded and nocturnal blood pressure dipping can 
be studied (184). Reduced nocturnal blood pressure dipping in adolescents with obesity has 
been recorded using 24-hour ABPM (59, 60). In Study II, 42% of prepubertal and early 
pubertal children with obesity were systolic non-dippers, a figure almost as high as that for 
adolescents with obesity (60). The effect of non-dipping in children and adolescents has been 
less studied than in adults, and the associations found with CV risk factors inconclusive. In 
adults, non-dipping is associated with LVH (61), CVD (62) and increased mortality (63), 
which would make this high prevalence even more worrisome if the non-dipping persisted 
into adulthood. However, in Study III, tracking only of SBP dipping was evident, and the 
non-dipping present in childhood was resolved to a large extent, and in addition did not 
predict end-organ damage in young adulthood. This might indicate that the high prevalence 
of non-dipping seen in childhood is less important for the future CV health of these 
individuals. On the other hand, the prevalence of hypertension, which influences the dipping, 
seems to fluctuate throughout adulthood (217), and may affect dipping and other factors 
measured more or less depending on at what age it is studied. Despite the absence of 
prediction of end-organ damage in Study III at the specific ages evaluated, childhood non-
dipping may play a role in future CV health if followed up later. 
The mechanisms behind dipping are not fully understood, but the duration of obesity might 
also have an impact here (218). A sympathovagal imbalance is present in children with 
obesity compared to those without obesity (219), but is especially evident among those with a 
shorter duration of obesity (218). Among these non-diabetic prepubertal and early pubertal 
children (Study II), measures of insulin metabolism were not associated with dipping as have 
been found among adolescents (60) and adults (220), high insulin levels developing later, 
probably will enhance the imbalance further. Despite the fact that OSA was present in some 
children, it was not related to dipping or the LVM index in this group. Measures of insulin 
and glucose metabolism or blood pressure, including dipping, were not associated with the 
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LVM index, even though the prevalence of non-dipping was high, and some subjects had 
hypertension. In more recent studies, non-dipping was again not associated with an increased 
LVM index among children and adolescents with obesity and suspected hypertension (68), or 
among non-obese but hypertensive children (69). The non-diabetic state and fairly healthy 
levels of most factors may have contributed to the absence of associations in Study II. 
5.4 CLINICAL SIGNIFICANCE OF MEASURING CARDIOVASCULAR RISK 
FACTORS IN CHILDHOOD 
When children with a high degree of obesity are admitted to treatment at our highly 
specialized clinic, the National Childhood Obesity Centre, an extended clinical investigation 
is performed. The goal of treatment is weight loss, which is hard to achieve, especially among 
adolescents (153). Effective treatment requires very intensive behavioural intervention (221), 
which is difficult to offer to all adolescents with obesity.  
In a very recent study in children with obesity, association between high fat mass through 
adolescence and arterial stiffness was found (222). In studies of general populations, 
associations between CV risk factors in childhood and measures of end-organ function in 
adulthood have been found (122, 124-126). Although it is important to study large cohorts, it 
is unclear whether monitoring different CV risk factors are of value for clinical decision-
making and the identification of children and adolescents with obesity with the highest risk of 
early development of CVD. The well-established CV risk factors measured during treatment 
might therefore contribute to identifying those at highest risk of developing obesity-related 
comorbidities in young adulthood, and enable offering them optimal treatment. 
In the longitudinal study of young adults who had previously been in childhood obesity 
treatment (Study III), associations were found between elevated total cholesterol, 
triglycerides, and daytime SBP in childhood and increased cIMT in young adulthood. The 
associations with cIMT were adjusted for sex, smoking in young adulthood, and changes in 
BMI SDS in young adulthood in order to adjust for known differences between the sexes in 
the studied variables, diminish the known effects of smoking on cIMT, and reduce the known 
effects of weight change. Adjustments for passive smoking during childhood were not 
performed, but may have affected the associations found, since passive smoking has also 
been found to be related to cIMT (104) and endothelial function (103). 
The hypothesis that children and adolescents with obesity and present CV risk factors are 
predisposed to develop early signs of adverse CV end-organ function in young adulthood, 
and that these childhood risk factors might be used clinically must be revised: most of the 
childhood risk factors do not seem to predict adverse end-organ function in these young 
adults as in adults older than the cohort in Study III. Juonala and colleagues (145) showed 
that CV risk factors measured from the age of 9 were predictive of end-organ function in 
adulthood. In Study III, all subjects were at minimum 9 years old with a mean age of 14 
years, but even so, few associations were found. Obesity during childhood and adolescence 
may involve mechanisms increasing a physiological plasticity not possible if obesity occurs 
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in adulthood why the predictive value of childhood CV risk factors in children and 
adolescents with obesity is inconsistent and reduced. Or, the individuals included in the study 
may have been healthier than non-participants, and the results might have been different if 
studying both the present participants and non-participants had been possible. 
However, the general populations studied usually were older at adulthood, and in most of the 
studies childhood CV risk factors were measured before the rise of the obesity epidemic; 
these differences need to be considered, and may be significant. In the present study, subjects 
who previously attended childhood obesity treatment were studied in young adulthood.  
About 40% of subjects were in early puberty at the time of childhood measurements, a status 
associated with a worsened metabolic state (for example, insulin resistance); this may have 
adversely influenced CV risk factors and contributed to the prevalence of CV risk factors 
observed. On the other hand, obesity itself, independent of pubertal influence, is associated 
with these risk factors, and they probably would have been present even if all the subjects had 
been in late puberty. One factor that has been shown in Study I and others (208, 218) to 
influence results in the obese state is the duration of obesity. This was not considered in this 
longitudinal study, however, but it would have been interesting to adjust for, especially if the 
population had been larger, to allow for more confounding factors in the statistical analyses. 
Even though 29% of subjects decreased their BMI SDS at a clinically significant level from 
childhood to young adulthood, the distribution of BMI classes did not change. Severe 
obesity was present in 74% in young adulthood, despite participation in more than 3 years 
of childhood obesity treatment. Only 6% of subjects became normal weight. A high 
prevalence of persistent obesity has also been seen among young Japanese adults who 
previously participated in childhood obesity treatment (146). However, the follow-up in 
that study was performed via questionnaire, and analyses of childhood predictors were not 
performed. Nevertheless, evaluations showed that those with persistent obesity had higher 
prevalences of chronic diseases. The trend for obesity to persist among so many adolescents 
into adulthood must be decreased. This may partially be addressed by initiating treatment 
earlier, which has been shown to be effective, but something must also be done for those 
who do not receive treatment in time. 
The lower prevalence of CV risk factors in adulthood compared to childhood may be in part 
influenced by the different cut-offs used for adults, since the mean values did not change 
drastically during the time between measurements. The prevalence of increased cIMT (223-
225) and low CRF (154, 226) in young adulthood was high and concerning, since several 
studies have predicted CVD in adulthood using these risk factors. The level of cIMT in 
these young adults with a high persistence of severe obesity was about the same as the level 
in adults 10–15 years older, which is worrying. In addition, MetS, hypertension and low 
HDL cholesterol levels were present in 30%–40% of the individuals in young adulthood, 
which adds to their future risk of CVD, as seen among adults (223, 227). 
The levels of childhood CV risk factors may be more predictive for future adverse end-organ 
function if a follow-up of this cohort were to be done in another 10 years; as of now, 
however, the cohort may still be too young. 
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5.5 THE EFFECT OF SUPERVISED EXERCISE ON CARDIORESPIRATORY 
FITNESS AND CARDIOVASCULAR RISK FACTORS 
Treatment of adolescents is challenging for childhood obesity clinicians.  It has been shown 
that BMI SDS in adolescents with obesity does not improve to the same extent as in younger 
children in treatment (153), and therefore the CV risk factors present cannot be improved via 
weight reduction. Clinicians need other approaches in order to handle the prevalence of CV 
risk factors among adolescents with obesity so as to reduce the future risk of CVD. Numerous 
CV risk factors in both children and adolescents with overweight or obesity have been 
improved by aerobic exercise without weight loss (158-160, 162, 164, 165), and therefore 
exercise may be one alternative as a complement to obesity treatment in adolescents. 
However, challenges regarding how to get adolescents with obesity to start exercising and to 
feel comfortable exercising need to be considered. Therefore, the 3-month period of a 
supervised individualised aerobic exercise regimen in Study IV was carefully designed 
according to the following criteria to increase the odds of exercise maintenance after the end 
of the supervised period: 
 In respomce to meet requests from participants in an unpublished pilotstudy and the 
results from a published study (174), supervision by a personal coach was provided 
to give the needed guidance and support instead of group sessions. 
 The exercise activity was chosen by the coach and adolescent together in order to 
reach the heart rate goal, but at the same time find an activity that might be joyful in 
order to increase interest and improve the attitude towards exercise (172, 173). 
 The activity was performed close to the adolescent’s home or school in order to be 
time-efficient (173). 
 The intensity was adjusted to the adolescent’s capacity at baseline, and was slowly 
increased so that the adolescent would feel more comfortable with the exercise (176). 
 This exercise regimen was not enough to implement physical activity habits that would 
improve long-term CRF. However, short-term CRF improved compared to a non-exercise 
group during the supervised period, but without changes or differences in anthropometric 
measurements throughout the study. CRF can be used as an indicator of compliance with the 
exercise regimen, and the impairment in CRF seen during the 9 months following the 
supervised period therefore indicate poor compliance during this time period. This indicates 
that a personal coach is needed to ensure the performance of exercise on a regular basis, and 
is needed for a longer time period than that provided in this study. 
Even though short-term CRF improved, no effects on health-related quality of life were seen; 
this might be because the adolescents rated their health-related quality of life higher at 
baseline compared to others who improved their health-related quality of life after aerobic 
exercise (173), or the exercise period was simply too short to improve quality of life. 
In addition, measured objectively, total physical activity did not change after the supervised 
exercise, which is in line with other studies (228), and in line with the theory that total 
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physical activity level is hard to change in children (166). If the adolescents performed 
exercise 3 times a week for 3 months and did not reduce their physical activity during the 
remainder of the day, total physical activity would have increased. However, when physical 
activity was objectively measured for 7 consecutive days after the supervised period, exercise 
might accidentally have been performed outside the 7 days of measurement, or have been 
performed on a day that was later excluded because of too little total time registered, thereby 
contributing to the absence of increased total physical activity. 
No effects were seen on CV risk factors after the 3 months of supervised aerobic exercise, 
despite improvements in CRF without weight loss. However, arterial stiffness, measured as 
AIx@HR75, improved after the 9 months following the period of supervised exercise. Others 
have found an association between CRF and arterial stiffness (99, 100), but in healthy 
children and adolescents. In a study of children with overweight or obesity, an exercise 
regimen including resistance training with a duration of exercise that was almost double that 
in Study IV resulted in an improvement in endothelial cell function measured as the level of 
endothelial progenitor cells in the blood (229).  
One reason for the absent effect on CV risk factors may be that the subjects were too healthy, 
though others found no effect from exercise on FMD in those already having normal levels 
(155). Or, it may be that the supervised exercise intervention period was too short to have an 
effect on the CV risk factors measured.  
Although factors of known importance for participation and compliance were included, this 
was not sufficient for long-term exercise habits to be implemented among adolescents with 
obesity. 
5.5.1 What is needed to induce long-term performance of exercise in 
adolescents with obesity?  
In months 3 to 6, the adolescents were contacted by telephone to provide support after the 
supervised period. However, this support does not seem to have been enough to induce them 
to continue the exercise. 
Perhaps an exercise app could be used in smartphones as a complement to supervised 
exercise in obesity treatment. The app should have an exercise schedule/diary to be filled in 
after the period of exercise, with some kind of feedback afterwards and reminders when 
exercise has not been performed. However, smart phones and the use of apps were not as 
available at the time Study IV was begun as they are today. 
My experiences in Study IV are that several of the adolescents seemed to have lost hope for 
the future and of being able to make changes; instead, some seemed to “buy into the 
situation” and shut themselves in. The stigma around obesity probably also contributed to the 
fact that these individuals did not dare go to public places to perform exercise. Even though 
some adolescents reported that they performed the supervised exercise in Study IV because it 
was fun, others reported participating so as not to disappoint the coach and leave him or her 
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waiting unnecessarily for them to arrive. To perform exercise because of it is fun is an 
intrinsic motivation, however, to perform exercise so as not to disappoint the coach is an 
extrinsic motivation, and of disadvantage for maintaining long-term exercise. 
In a previous study, adolescents with obesity reported more extrinsic motivations (e.g. 
losing weight and looking better) than intrinsic motivations (e.g. pleasure and satisfaction) 
for being physically active compared to normal-weight adolescents (172). Intrinsic factors 
are known to be more effective in motivating long-term participation (230), and may 
therefore be something to focus more upon in future interventions aimed at inducing regular 
exercise in subjects with obesity. However, expectations for the goal that are too high to be 
achieved when performing exercise have also been shown to result in failure (231). 
Adolescents in Study IV did not reduce their weight but only improved their CRF, which 
may have contributed to a reduction in motivation for continuing the exercise after the 
supervised period, even though the goal of the study was not to reduce their weight. Setting 
clear, realistic and reachable goals seems important for success. 
5.6 METHODOLOGICAL CONSIDERATIONS NOT PREVIOUSLY DISCUSSED  
In this section I will discuss methodological considerations that have not previously been 
noted.  
5.6.1 BMI and BMI SDS 
BMI used for the evaluation of body composition is highly dependent on height and cannot 
distinguish between muscle mass, subcutaneous and abdominal, or visceral adiposity, but is 
very easy to use and inexpensive. DXA is a more reliable and precise method, but is more 
expensive and/or complicated to perform in a clinical or research setting; therefore, BMI is 
still frequently used to evaluate body composition. 
In order to be able to compare BMI between ages or genders, or to follow BMI over time 
(especially in childhood), BMI SDS is calculated. There are different references used, and the 
degree of obesity will differ depending on the reference population used. In this thesis, it is 
important to remember that three different references were used. Roland-Cachera et al. (17) 
and Karlberg et al. (18) are traditionally used in clinical settings, and were thus used in the 
first two studies. To be able to make comparisons with other studies, the IOTF reference (16), 
more commonly used internationally, was used in Studies III and IV. 
The cut-off used in Study III for a reduction in BMI SDS was chosen because of studies 
showing a clinically significant effect on CV risk factors with this reduction (149). However, 
a greater reduction has a greater effect on CV risk factors (147-149). 
5.6.2 Biochemical analyses 
In cases in which analytical methods changed during the study period and were needed for 
comparison, results from one analytic method used at one time point were recalculated into 
units/levels of another method used at another time point in the study.  
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For example, the analytical method changed during data collection for insulin in Study II, so 
results for affected subjects were recalculated into the units/levels of the newer method used 
by the laboratory. 
Note that the analytical method used for HbA1c in Studies I and II was older than that used in 
Study IV; the units therefore differ between the studies, and are not comparable. Results are 
presented in percentages in Studies I and II, and when the newer International Federation of 
Clinical Chemistry and Laboratory Medicine (IFCC) method began to be used in Study IV, 
the results were presented as mmol/mol, and are consequently at higher levels than in Studies 
I and II.  
5.6.3 Pulse wave analysis 
Pulse wave analysis (PWA) is a method for determining systemic arterial stiffness as the 
augmentation index (AIx), derived from the radial artery waveform (194) and by using a 
general transfer function (195) converted to an estimated aortic pressure waveform in Studies 
II and IV. The pulse waveforms measured with PWA are quite similar to those measured 
with catheterisation (194); however, the carotid-femoral pulse wave velocity (PWV) method 
is considered the gold standard for measuring arterial stiffness, but at the regional site (232). 
Briefly, PWV measures the speed of the pulse wave as it travels from the carotid artery to the 
femoral artery by measuring the distance between the two sites and the time the pulse wave 
takes to travel this distance. The speed is correlated to arterial stiffness. PWA, however, was 
the primary choice of measurement for arterial stiffness here for the following reasons: 
 To increase compliance; PWA does not require the subject to remove clothing (as is 
the case with the PWV method), which may be perceived as uncomfortable by 
subjects, especially those with obesity.  
 To make it easier to perform measurements: it is more difficult to measure the 
distance from the carotid artery to the femoral artery in subjects with obesity, since 
the belly is in the way.  
 Because PWA may be more sensitive for subjects < 50 years old, since the AIx 
increases more in younger people than the PWV, which instead seems more suitable 
for older subjects.  
In addition, PWA is portable, cost-effective, user-independent, and quick and easy to 
perform. 
Consensus about cut-offs for adverse levels of arterial stiffness, measured as AIx or 
AIx@HR75 by PWA, is not available. In Study III, the mean level at young adulthood was 
therefore compared with a Danish population of comparable age but with a low risk of CVD 
(233). A negative value is advantageous, and is often seen among younger subjects. 
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5.6.4 Metabolic syndrome 
Consensus about classification of MetS is still being debated, and several references have 
been available over the years. In Studies III and IV, the widely used references by Zimmet et 
al. for children and adolescents (182) and Alberti et al. for adults (183) were used. The 
greatest difference between these references, besides the cut-offs for some included variables, 
is that for adults, obesity or an elevated waist circumference is not one of the three required 
criteria for having MetS.  
5.6.5 24-hour ambulatory blood pressure monitoring 
In order to record 24-hour blood pressure and be able to calculate dipping, 24-hour ABPM, 
which is considered superior to in-office blood pressure, was included in all studies. Although 
24-hour ABPM is not considered to be highly reproducible if using general sleep-wake hours 
(51), when the actual sleep-wake hours from the diary are taken into account, the sleep-
induced SBP dipping is very reproducible (234). Having subjects in this patient group 
complete the measurement twice would have been hard to achieve, since most of the subjects 
felt uncomfortable with performing even one measurement. Therefore, the measurement was 
only reproduced if the participant felt that he or she had an abnormal day or night during the 
measurement, such as a bad night’s sleep, since a bad night’s sleep is associated with a non-
representative measurement (235). The ideal, of course, would have been to repeat the 
measurement to confirm the first measurement. 
5.6.6 Submaximal bicycle test 
In order to follow CRF over time, the submaximal bicycle test by Åstrand (185) was 
performed, since this was also the test performed at admission to the National Childhood 
Obesity Centre, and hence had already been obtained in childhood for those included in 
Study III. The same test was performed in Studies I and IV. An alternative would have been a 
maximal oxygen consumption test, which correlates well with the submaximal test (236). 
However, since this group of children and adolescents with obesity is known to usually have 
a low degree of exercise experience and hence low CRF (237), the less advanced submaximal 
bicycle test was a more suitable choice for this group. The submaximal test is built on the 
assumption that heart rate, work load and oxygen consumption are linearly related. When 
heart rate increases during the test due to increased work load, oxygen consumption 
increases. The submaximal test does not require advanced laboratory equipment and the 
presence of a medical specialist, as does the VO2 max test. However, it has its limitations, 
such as the extrapolation of maximal oxygen consumption from the heart rate obtained, or 
nervousness and emotions affecting the heart rate. The test was performed on two different 
bicycles (one electronically-braked and the other mechanically-braked) in Study III. In order 
for tests performed with the different bicycles to be comparable, maximum VO2 estimates 
were made using the Siconolfi computation (238) of the Åstrand nomogram from 1960 after 
transformation of watt to kilopond meter (239), and thereafter, age and sex adjustments were 
performed (185). In Study III, where the degree of CRF was classified according to Anderson 
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et al. (188), CRF for children younger than 15 years old was obtained from extrapolated 
values used in clinical settings in Sweden. 
5.6.7 Accelerometry 
The accelerometer Actiwatch
®
 (AW, Model 4; Cambridge Neurotechnology Ltd, Cambridge, 
United Kingdom) was used in Study IV because it is validated for measuring activity during 
sleep (240); however, sleep measurements were not included here, which is a limitation 
(190). This accelerometer is easy to wear on the wrist, which was believed would increase 
compliance among children and adolescents, and in addition register the sort of low-intensity 
activity which was suspected to be present among the adolescents with obesity, since it has 
been shown that they participate less in organised sports compared to normal-weight 
adolescents (237). The 15-second epoch length used is suitable for adolescents (241), and 
enables the registration of shorter boosts in physical activity. 
The wrist-worn accelerometer used in Study III has been validated against the Actigraph hip-
worn accelerometer. The cut-offs used for intensities of physical activity were obtained and 
used by others in Sweden (190) studying children aged 8–10, which is a limitation.  
5.6.8 Glucose tolerance tests 
Frequently sampled intravenous glucose tolerance tests (FSIVGTT) were performed at 
enrolment in the National Childhood Obesity Centre and were included in the BORIS 
register; as such, they were included in Studies I and II. In Study IV, an oral glucose tolerance 
test (OGTT) was performed. These two tests are not interchangeable, since they measure 
different aspects of insulin-glucose metabolism (193).  
The gold standard for measuring insulin sensitivity is the invasive euglycemic 
hyperinsulinemic clamp, which measures β cell sensitivity to glucose and the sensitivity of 
body tissues to insulin. However, this method is very advanced, time consuming, expensive, 
and can be negatively perceived by the subject; it is therefore rarely used in clinical settings 
today. 
The FSIVGTT is less advanced and expensive than the euglycemic hyperinsulinemic clamp. 
FSIVGTT is highly reliable and reproducible, and the results for insulin sensitivity using 
FSIVGTT and the euglycemic hyperinsulinemic clamp are highly correlated, at least among 
those who do not have extreme insulin resistance. An advantage of the FSIVGTT is its ability 
to identify and separate distinct components of glucose disposal. 
The OGTT is used after fasting glucose sampling to confirm and diagnose T2DM or impaired 
glucose tolerance, and does not measure insulin sensitivity. It is very easy to perform and 
much cheaper than the euglycemic hyperinsulinemic clamp and the FSIVGTT, and is 
therefore often used in both research and clinical settings. OGTT does not require two nurses, 
as does the FSIVGTT, during the period of time before the glucose is injected. Limitations 
with this method, however, are that gastric emptying and glucose absorption from the 
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gastrointestinal tract vary between subjects, which affect reproducibility even with the same 
subjects. Further, it is a relatively imprecise measure of glucose tolerance, and does not 
measure specific components as with FSIVGTT. 
5.6.9 Echocardiography 
Absolute LVM varies with sex and ethnicity, and values need to account for physiological 
variations related to body size. It is possible to index LVM obtained via echocardiography in 
different ways, and indexing for body surface area or height with an allometric exponent of 
2.7 may be the most common (82). It has been concluded, however, that indexing for body 
surface area underestimates LVH in subjects with obesity, and that indexing for height with 
an exponent of 2.7 is more suitable. This indexing also reduces the variability among normal-
weight subjects. Indexing for height is thought to take into account growth during childhood 
and approximate for lean body mass. 
It is also possible to measure LVM using cardiac magnetic resonance; however, 
echocardiography is the method preferred, since it is cheaper, more available and accepted for 
measuring LVM. The two methods are not interchangeable, and the absolute values obtained 
differ between methods; however, cardiac magnetic resonance provides a more accurate and 
precise measure of LVM (82). 
The cut-off for an abnormal LVM index can differ depending on the reference; in this thesis, 
the references by Khoury et al. for children (201) and Lang et al. for adults (197) were used.  
5.6.10 Ultrasonography of the carotid arteries 
Carotid intima-media thickness is relatively simple to measure non-invasively with 
ultrasonography. The reference used for abnormal cIMT levels, according to sex and age, was 
Engelen et al. (202). Unfortunately, cIMT was not included in the extensive investigation at 
admission to the National Childhood Obesity Centre in Study III, and it is therefore not 
possible to follow it from childhood to young adulthood. If it had been available, it would 
have been interesting, since the prevalence of high cIMT turned out to be high in young 
adulthood. This raises questions about the levels of cIMT in childhood: Were the levels 
already elevated, and to what extent if so? Was the cIMT already associated with the same 
risk factors in childhood? Would childhood levels track to young adulthood?  
5.6.11 Recruitment and study populations 
In Studies I, II and III, the study populations were dependent on the information reported in 
the BORIS register and related medical records of the measurements focused upon. In Study 
IV, the population was dependent on the flux of adolescents meeting their medical doctors at 
the National Childhood Obesity Centre and the involved outpatient clinics, and the doctors’ 
decisions about the adolescents’ suitability to participate based on the inclusion and exclusion 
criteria. However, after the adolescents were identified, randomization to one of the three 
groups was performed at the visit for baseline examinations. Since the recruitment turned out 
to be more difficult than expected, it was decided to terminate the study. This was in part 
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because of the flux of adolescents at the clinics and their clinical situations, contraindicated to 
the inclusion and exclusion criteria, but also due to a high dropout rate among controls. 
Therefore, only the exercise regimen was evaluated in Study IV, and the four populations are 
consequently somewhat selected with regard to the above aspects. 
Factors such as the stigmatisation of subjects with obesity probably contributed to the 
difficulties with recruitment and with performing studies in the patient group with obesity.  
The results may have been affected by missing data due to the unwillingness of this group to 
be examined, especially the adolescents, who can be hard to deal with even when they are of 
normal weight. 
In Study III, a large part of the eligible subjects declined to participate or had undergone 
bariatric surgery. Perhaps failed childhood obesity treatment contributed to unwillingness to 
participate and be re-examined. Maybe those who were included in Study III were healthier 
and more motivated, and therefore more successful than those who declined to participate or 
had undergone bariatric surgery. 
In Study IV, most of the subjects hoped to be randomised to the exercise intervention. 
However, those randomised to metformin therapy were fairly satisfied, while the controls 
were disappointed at “getting nothing”, which was one primary reason for dropouts in the 
control group. The control subjects were therefore offered the opportunity to perform 
supervised exercise for a 1-month period later on, after their participation had been 
completed.  
Dropout rates among adolescents in treatment at the National Childhood Obesity Centre have 
been found to be as high as 70% after 3 years (242). In addition, treatment effects on BMI 
SDS have been low, which indicates there are general difficulties in working with 
adolescents. A high dropout rate is common in intervention studies. As a result, the 
combination of an intervention study among adolescents with obesity is hard to perform 
successfully. 
Variations in individual childhood obesity treatments may have had an impact on the results. 
5.6.12 Statistical implications 
The statistical methods used and adjustments for confounding factors were limited by the size 
of the study populations. Non-parametric tests were used in some cases, primarily because of 
a limited study population. 
In addition, missing data occurs in all four studies in different ways, which may therefore 
affect the results. However, this is also what clinicians experience when working with a 
population with obesity, and especially children and adolescents. Resistance to performing 
different physical examinations or to having blood samples taken, or even to showing up at 
an appointment are daily obstacles the clinicians must face. 
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In Study II, adjustments for pubertal status were made; this was not possible, however, in the 
other studies, and pubertal status may therefore have influenced the results. 
5.7 CLINICAL IMPLICATIONS 
It is important for clinicians working with childhood obesity to be aware of the comorbidities 
present, know which of them are important to treat, and know how to treat them. In Studies I 
and II, the obesity comorbidities microvascular endothelial dysfunction and non-dipping were 
present in children and adolescents with obesity attending childhood obesity treatment. 
In Study III, several CV risk factors were present in childhood, but many prevalences also 
decreased in young adulthood; this may not always have been due to improved values, but 
rather causes such as cut-offs that differed from those for abnormal levels in childhood. The 
subjects were in a pubertal stage that is related to poorer insulin sensitivity, which is linked 
to the presence of several other risk factors; this may have contributed to the improvements 
seen in young adults, although this was to some extent a natural development.  
Since the CV risk factors present among children and adolescents with obesity resolve to a 
high extent in young adulthood, one may wonder about the significance of testing methods to 
improve these risk factors in children and adolescents. However, since obesity in childhood 
and adolescence persist into young adulthood and thereafter at a high level, and CV risk 
factors in adults with obesity are highly present and predict CVD and mortality, it still feels 
meaningful to try to improve CV risk factors present in childhood and adolescence if weight 
loss is not effective. If weight loss is not effective, these subjects are almost doomed to have 
obesity in adulthood, and therefore will be at high risk for CVD. And if some improvements 
during childhood and adolescence make a difference in future CV health, they are worth 
trying.  
The exercise regimen tested in Study IV turned out not to be very effective in improving CV 
risk factors as hypothesised, and cannot be recommended for implementation in clinical 
practice as a complement to obesity treatment in adolescents. However, clinicians should 
continue to encourage exercise, since it has shown positive effects in larger studies, although 
implementation of the particular regimen covered in this study might not be economically 
justified at clinics. Possible ways to minimise CV risk factors of importance for CV health in 
young adulthood might instead be pharmacological treatment of the high childhood levels of 
blood lipids, and maybe also blood pressure, which was found to be predictive of cIMT in 
Study III. 
5.8 FUTURE RESEARCH 
If possible, of course, weight loss would be the focus in childhood obesity treatment, since it 
is effective in reducing common CV risk factors. However, where weight loss is hard to 
achieve, as in adolescents, the effects and sustainability of lifestyle changes—such as 
increased physical activity/exercise, perhaps in combination with diet changes—should be 
studied. Emphasizing intrinsic motivations for change and having realistic and achievable 
expectations are important factors for lifestyle changes, and hence would be a focus as a 
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complement to the struggles with losing weight for children and, especially, adolescents. 
However, until it is possible to perform larger studies of how lifestyle changes implemented 
in childhood affect CV risk factors and CV health in adulthood among those who have 
participated in childhood obesity treatment, clinicians have to keep on struggling with what 
CV risk factors should be treated during childhood to decrease future CV risk in this group. 
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6 CONCLUSIONS 
CV risk factors were already present in childhood in this group of severely obese patients. 
Disturbed endothelial function (measured as microvascular acetylcholine-induced 
endothelium-dependent dilatation) was present at an early age, and was affected by the 
duration of obesity in children with obesity without comorbidities compared to normal-
weight controls. 
Blunted nocturnal blood pressure dipping was twice as prevalent in prepubertal and early 
pubertal children with severe obesity compared to results from previous studies on children in 
general. Dyslipidemia and low CRF were highly prevalent, whereas a high LVM index and 
MetS were present among 20%–24% of the children. Hypertension was uncommon in 
childhood. 
Endothelial function and nocturnal blood pressure dipping in children with severe obesity 
were not associated with insulin-glucose metabolism, as has been observed by others among 
adolescents with obesity. 
Few childhood CV risk factors were predictive of adverse end-organ function in young 
adulthood; it does seem important, however, to monitor blood pressure, triglycerides and total 
cholesterol. 
Clinicians should pay attention to the treatment of high childhood triglycerides, levels of total 
cholesterol and systolic daytime blood pressure, since these were found to be predictive of 
cIMT in young adults who had been in childhood obesity treatment. CRF can be improved 
via 3 months of supervised aerobic exercise. However, CRF decreased to baseline levels 
during the 9 months following the supervised exercise, and only small effects on CV risk 
factors were seen. As such, this exercise regimen cannot be recommended for implementation 
in clinical settings. 
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